<SEC-DOCUMENT>0001217234-25-000064.txt : 20251104
<SEC-HEADER>0001217234-25-000064.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104162657
ACCESSION NUMBER:		0001217234-25-000064
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104
EFFECTIVENESS DATE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CareDx, Inc.
		CENTRAL INDEX KEY:			0001217234
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				943316839
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291254
		FILM NUMBER:		251449558

	BUSINESS ADDRESS:	
		STREET 1:		8000 MARINA BLVD
		STREET 2:		4TH FLOOR
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		415-287-2300

	MAIL ADDRESS:	
		STREET 1:		8000 MARINA BLVD
		STREET 2:		4TH FLOOR
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XDx, Inc.
		DATE OF NAME CHANGE:	20071010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXPRESSION DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20030203
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>cdna-formsx82024eip2025ind.htm
<DESCRIPTION>S-8
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i9bf3ddaad4b74c62bd7df931bc0bbfef_1"></div><div style="background-color:#ffffff"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">As filed with the Securities and Exchange Commission on November 4, 2025</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registration No. 333-</font></div><div style="margin-top:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM S-8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNDER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">THE SECURITIES ACT OF 1933</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%">CareDx, Inc.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.805%"><tr><td style="width:1.0%"></td><td style="width:49.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">94-3316839</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction of</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">incorporation or organization)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</font></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8000 Marina Boulevard, 4th Floor</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Brisbane, California 94005</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CareDx, Inc. 2024 Equity Incentive Plan</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CareDx, Inc. 2025 Inducement Equity Incentive Plan</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Full titles of the plans)</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">John W. Hanna</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">President and Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CareDx, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8000 Marina Boulevard, 4th Floor</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Brisbane, California 94005</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(415) 287-2300</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Name, address and telephone number, including area code, of agent for service)</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Copies to&#58;</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Douglas N. Cogen, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Robert A. Freedman, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Chelsea Anderson, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Fenwick &#38; West LLP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">801 California Street</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mountain View, California 94041</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(650) 988-8500</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.944%"><tr><td style="width:1.0%"></td><td style="width:21.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><div id="i9bf3ddaad4b74c62bd7df931bc0bbfef_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE</font></div><div style="margin-bottom:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Registration Statement on Form S-8 (this &#8220;Registration Statement&#8221;) is filed by CareDx, Inc. (the &#8220;Registrant&#8221;) to register (i) 1,600,000 additional shares of the Registrant&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), issuable pursuant to the Registrant&#8217;s 2024 Equity Incentive Plan, as amended by Amendment No. 1, dated as of April 23, 2025 (the &#8220;2024 Plan&#8221;), and (ii) 350,000 shares of Common Stock issuable pursuant to the Registrant&#8217;s 2025 Inducement Equity Incentive Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART I</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The document(s) containing the information specified in Part I will be sent or given to employees as specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 of the Securities Act. Such documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II hereof, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Incorporation of Documents by Reference.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following documents filed by CareDx, Inc. (the &#8220;Registrant&#8221;) with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) are hereby incorporated by reference into this Registration Statement on Form S-8 (this &#8220;Registration Statement&#8221;)&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">The Registrant&#8217;s Annual Report on </font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1217234/000121723425000012/cdna-20241231.htm" style="-sec-extract:exhibit;color:#467886;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> for the fiscal year ended December 31, 2024, filed with the Commission on February 28, 2025&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">all other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;) since the end of the fiscal year covered by the Registrant&#8217;s Annual Report referred to in (a) above&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">the description of the Common Stock set forth in the Registration Statement on Form 8-A (</font><font style="color:#467886;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000119312514266632/d754504d8a12b.htm" style="-sec-extract:exhibit;color:#467886;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">File No. 001-36536</a></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">), filed with the Commission on July 11, 2014, including any amendments or reports filed for the purpose of updating such description.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All other reports and other documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part of this Registration Statement from the date of the filing of such reports and documents, except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under Items 2.02 or 7.01 of Form 8-K that is not deemed filed under such provisions.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You should rely only on the information provided or incorporated by reference in this Registration Statement or any related prospectus. The Registrant has not authorized anyone to provide you with different information. You </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">should not assume that the information in this Registration Statement or any related prospectus is accurate as of any date other than the date on the front of the document.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You may contact the Registrant in writing or orally to request copies of the above-referenced filings, without charge (excluding exhibits to such documents unless such exhibits are specifically incorporated by reference into the information incorporated into this Registration Statement). Requests for such information should be directed to&#58;</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">CareDx, Inc.</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8000 Marina Boulevard, 4th Floor</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California 94005</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(415) 287-2300</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Attn&#58; Investor Relations</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Description of Securities.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Interests of Named Experts and Counsel.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Indemnification of Directors and Officers.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Section 145 of the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;) authorizes a corporation&#8217;s board of directors to grant, and authorizes a court to award, indemnity to officers, directors and other corporate agents.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As permitted by Section 102(b)(7) of the DGCL, the Registrant&#8217;s amended and restated certificate of incorporation includes provisions that eliminate the personal liability of its directors and officers for monetary damages for breach of their fiduciary duty as directors and officers.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as permitted by Section 145 of the DGCL, the amended and restated certificate of incorporation and amended and restated bylaws of the Registrant provide that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Registrant shall indemnify its directors and officers for serving the Registrant in those capacities or for serving other business enterprises at the Registrant&#8217;s request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Registrant may, in its discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Registrant is required to advance expenses, as incurred, to its directors and officers in connection with defending a proceeding, except that such director or officer shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Registrant is not obligated pursuant to the amended and restated certificate of incorporation and amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person, except with respect to proceedings authorized by the Registrant&#8217;s board of directors or brought to enforce a right to indemnification.</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The rights conferred in the amended and restated certificate of incorporation and amended and restated bylaws are not exclusive, and the Registrant is authorized to enter into indemnification agreements with its directors, officers, employees and agents and to obtain insurance to indemnify such persons.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Registrant may not retroactively amend the bylaw provisions to reduce its indemnification obligations to directors, officers, employees and agents.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Registrant has entered into separate indemnification agreements with each of its directors and executive officers that provide the maximum indemnity allowed to directors and executive officers by Section 145 of the DGCL and also to provide for certain additional procedural protections. The Registrant also maintains directors and officers insurance to insure such persons against certain liabilities.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These indemnification provisions and the indemnification agreements entered into between the Registrant and its executive officers and directors may be sufficiently broad to permit indemnification of the Registrant&#8217;s executive officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See also the undertakings set out in response to Item 9 herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Exemption from Registration Claimed.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Exhibits.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-right:-2.38pt"><font style="color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000119312514325391/d757814dex31.htm" style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on August 28, 2014 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-right:-2.38pt"><font style="color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000119312521193438/d93632dex31.htm" style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.1 to the Registrant&#8217;s Current Report on Form&#160;8-K&#160;filed on June&#160;21, 2021 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-right:-2.38pt"><font style="color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000121723423000107/caredx-certificateofamendm.htm" style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.1 to the Registrant&#8217;s Current Report on Form&#160;8-K&#160;filed on June&#160;20, 2023 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-right:-2.38pt"><font style="color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000119312514325391/d757814dex34.htm" style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amended and Restated Bylaws (previously filed as Exhibit 3.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed on August 28, 2014 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-right:-2.38pt"><font style="color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000119312515113712/d852478dex41.htm" style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Registrant&#8217;s Common Stock Certificate (previously filed as Exhibit 4.1 to the Registrant&#8217;s Annual Report on Form 10-K filed on March 31, 2015 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit51-opinionformsx8.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Opinion of Fenwick &#38; West LLP.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit231-deloitteformsx8.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of Deloitte &#38; Touche LLP, Independent Registered Public Accounting Firm.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23.3*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit51-opinionformsx8.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of Fenwick &#38; West LLP (contained in Exhibit 5.1).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i9bf3ddaad4b74c62bd7df931bc0bbfef_7" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Power of Attorney (contained on the signature page).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-right:-2.38pt"><font style="color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000121723424000071/caredxinc2024equityincenti.htm" style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CareDx, Inc. 2024 Equity Incentive Plan (previously filed as Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on June 18, 2024 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1217234/000119312525139978/d927352dex101.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. 1 to the CareDx, Inc. 2024 Equity Incentive Plan (previously filed as Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed on June 12, 2025 and incorporated herein by reference).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.3*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit993-2025inducementp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CareDx, Inc. 2025 Inducement Equity Incentive Plan and the forms of award agreements thereunder.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">107*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exfilingfees.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Filing Fee Table.</a></font></div></td></tr></table></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Undertakings.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A. The undersigned Registrant hereby undertakes&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(i) To include any prospectus required by Section 10(a)(3) of the Securities Act&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, that paragraphs (A)(1)(i) and (A)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">B. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><div id="i9bf3ddaad4b74c62bd7df931bc0bbfef_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&#160;S-8&#160;and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Brisbane, California, on November 4, 2025.</font></div><div style="padding-left:283.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.583%"><tr><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CAREDX, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:7.62pt;padding-right:-2.38pt;text-indent:-10pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:7.62pt;padding-right:-2.38pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John W. Hanna</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.62pt;padding-right:-2.38pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">John W. Hanna</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.62pt;padding-right:-2.38pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">President and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, that each person whose signature appears below constitutes and appoints John W. Hanna and Nathan Smith, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.539%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Date</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; John W. Hanna</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">John W. Hanna</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">President, Chief Executive Officer and Director</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Nathan Smith</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nathan Smith</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Financial and Accounting Officer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; George W. Bickerstaff, III</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">George W. Bickerstaff, III</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Fred E. Cohen</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fred E. Cohen</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Christine M. Cournoyer</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Christine M. Cournoyer</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Michael Goldberg</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Michael Goldberg</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director and Chairman of the Board</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-1.19pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Suresh Gunasekaran</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Suresh Gunasekaran</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Peter Maag</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Peter Maag</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; R. Bryan Riggsbee</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">R. Bryan Riggsbee</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Arthur Torres</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Arthur Torres</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Hannah Valentine</font></div><div style="margin-bottom:1pt;padding-right:-2.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Hannah Valentine</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.62pt;padding-right:2.62pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2025</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:3499595a-dc92-44f5-9762-dca0e9e9a5fc,g:e3f76499-6122-4a5b-b9d3-a4946b15b68b,d:9a60cdaa26634c2da1154e8474b50892-->
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exfilingfees</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-3" name="dei:EntityCentralIndexKey" id="f-25">0001217234</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="dei:EntityRegistrantName" id="f-26">CAREDX, INC.</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="ffd:FormTp" id="f-27">S-8</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="ffd:SubmissnTp" id="f-28">S-8</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="ffd:FeeExhibitTp" id="f-29">EX-FILING FEES</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="ffd:OffsetTableNa" id="f-30">N/A</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-04</xbrli:startDate><xbrli:endDate>2025-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-04</xbrli:startDate><xbrli:endDate>2025-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001217234</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-04</xbrli:startDate><xbrli:endDate>2025-11-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9a60cdaa26634c2da1154e8474b50892_42"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 107</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Calculation of Filing Fee Table</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Form S-8</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Form Type)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CareDx, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table 1: Newly Registered Securities</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:0.1%"/><td style="width:2.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.720%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.944%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.631%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Security Type</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Security Class Title</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fee Calculation Rule</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.37pt;padding-right:1.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Amount Registered</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Proposed Maximum Offering Price Per Unit</span></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Aggregate Offering Price</span></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fee Rate</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Registration Fee</span></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="ffd:PrevslyPdFlg" format="ixt:fixed-false" id="f-1"><ix:nonNumeric contextRef="c-1" name="ffd:OfferingSctyTp" id="f-2">Equity</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><ix:nonNumeric contextRef="c-1" name="ffd:OfferingSctyTitl" id="f-3"><div style="padding-left:1.37pt;padding-right:-1.38pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">CareDx, Inc. 2024 </span></div><div style="padding-left:1.37pt;padding-right:-1.38pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">Equity Incentive Plan</span></div><div style="padding-left:1.37pt;padding-right:-1.38pt"><span><br/></span></div><div style="padding-left:1.37pt;padding-right:-1.38pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">Common Stock, par value $0.001 per share</span></div></ix:nonNumeric></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="ffd:FeesOthrRuleFlg" format="ixt:fixed-true" id="f-4">Rule 457(c) and Rule 457(h)</ix:nonNumeric></span></div></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.68pt;padding-right:0.68pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ffd:AmtSctiesRegd" format="ixt:num-dot-decimal" scale="0" id="f-5">1,600,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.01pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ffd:MaxOfferingPricPerScty" scale="0" id="f-6">14.53</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.69pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ffd:MaxAggtOfferingPric" format="ixt:num-dot-decimal" scale="0" id="f-7">23,248,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="8" name="ffd:FeeRate" scale="0" id="f-8">0.00015310</ix:nonFraction></span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ffd:FeeAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">3,560</ix:nonFraction></span></div></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="ffd:OfferingSctyTp" id="f-10"><ix:nonNumeric contextRef="c-2" name="ffd:PrevslyPdFlg" format="ixt:fixed-false" id="f-11">Equity</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:-1.38pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="ffd:OfferingSctyTitl" id="f-12" continuedAt="f-12-1">CareDx, Inc. 2025 Inducement Equity Incentive Plan</ix:nonNumeric></span></div><div style="padding-left:1.37pt;padding-right:-1.38pt"><span><br/></span></div><div style="padding-left:1.37pt;padding-right:-1.38pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="f-12-1">Common Stock, par value $0.001 per share</ix:continuation> </span></div></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:1.37pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="ffd:FeesOthrRuleFlg" format="ixt:fixed-true" id="f-13">Rule 457(c) and Rule 457(h)</ix:nonNumeric></span></div></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.68pt;padding-right:0.68pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="ffd:AmtSctiesRegd" format="ixt:num-dot-decimal" scale="0" id="f-14">350,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.01pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ffd:MaxOfferingPricPerScty" scale="0" id="f-15">14.53</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.69pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ffd:MaxAggtOfferingPric" format="ixt:num-dot-decimal" scale="0" id="f-16">5,085,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-2" decimals="8" name="ffd:FeeRate" scale="0" id="f-17">0.00015310</ix:nonFraction></span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ffd:FeeAmt" scale="0" id="f-18">779</ix:nonFraction></span></div></td></tr><tr><td colspan="36" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Offering Amounts:</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.69pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ffd:TtlOfferingAmt" format="ixt:num-dot-decimal" scale="0" id="f-19">28,333,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ffd:TtlFeeAmt" format="ixt:num-dot-decimal" scale="0" id="f-20">4,339</ix:nonFraction></span></div></td></tr><tr><td colspan="36" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Fee Offsets:</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ffd:TtlOffsetAmt" format="ixt:fixed-zero" scale="0" id="f-21">&#8212;</ix:nonFraction></span></div></td></tr><tr><td colspan="36" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Net Fee Due:</span></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ffd:NetFeeAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">4,339</ix:nonFraction></span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ffd:OfferingNote" id="f-24" continuedAt="f-24-1" escape="true"><ix:nonNumeric contextRef="c-2" name="ffd:OfferingNote" id="f-23" continuedAt="f-23-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement on Form&#160;S-8&#160;(the &#8220;Registration Statement&#8221;) shall also cover any additional shares of common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), of CareDx, Inc. (the &#8220;Registrant&#8221;) that become issuable under the CareDx, Inc. 2024 Equity Incentive Plan, as amended by Amendment No. 1, dated as of April 23, 2025 (the &#8220;2024 Plan&#8221;) and the CareDx, Inc. 2025 Inducement Equity Incentive Plan (the &#8220;2025 Inducement Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#8217;s outstanding shares of Common Stock.</span></ix:nonNumeric></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><ix:continuation id="f-24-1" continuedAt="f-24-2"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the number of additional shares of Common Stock that were reserved for issuance under the 2024 Plan.</span></ix:continuation></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><ix:continuation id="f-23-1" continuedAt="f-23-2"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the number of shares of Common Stock that were reserved for issuance under the 2025 Inducement Plan</span></ix:continuation></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><ix:continuation id="f-24-2"><ix:continuation id="f-23-2"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price with respect to these shares are calculated based on $14.53 per share, the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on October 30, 2025, a date within five business days prior to the filing of this Registration Statement.</span></ix:continuation></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table 2: Fee Offset Claims and Sources</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51-opinionformsx8.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5ae8ffc93c9345bdadeaac6ea0298463_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="fenwicklogoa.jpg" src="fenwicklogoa.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">November 4, 2025</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">CareDx, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8000 Marina Boulevard, 4th Floor</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Brisbane, California 94005</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Re&#58; Registration Statement on Form S-8</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">As counsel to CareDx, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), we have examined the Registration Statement on Form S-8 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to be filed by the Company with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Commission</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on or about November 4, 2025 in connection with the registration under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), of an aggregate of 1,950,000 shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of the Company&#8217;s common stock, $0.001 par value per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), that consists of (a)&#160;1,600,000 shares of Common Stock that are subject to issuance by the Company upon the exercise or settlement of awards to be granted under the Company&#8217;s 2024 Equity Incentive Plan, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2024</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and (b)&#160;350,000 shares of Common Stock that are subject to issuance by the Company upon the exercise or settlement of awards to be granted under the Company&#8217;s 2025 Inducement Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">2025 Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;, and together with the 2024 Plan, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Plans</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">As to matters of fact relevant to the opinions rendered herein, we have examined such documents, certificates and other instruments which we have deemed necessary or advisable, including a certificate addressed to us and dated the date hereof executed by the Company.  We have not undertaken any independent investigation to verify the accuracy of any such information, representations or warranties or to determine the existence or absence of any fact, and no inference as to our knowledge of the existence or absence of any fact should be drawn from our representation of the Company or the rendering of the opinion set forth below.  We have not considered parol evidence in connection with any of the agreements or instruments reviewed by us in connection with this letter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">In our examination of documents for purposes of this letter, we have assumed, and express no opinion as to, the genuineness and authenticity of all signatures on original documents, the authenticity and completeness of all documents submitted to us as originals, that each document is what it purports to be, the conformity to originals of all documents submitted to us as copies or facsimile copies, the absence of any termination, modification or waiver of or amendment to any document reviewed by us (other than as has been disclosed to us), the legal competence or capacity of all persons or entities (other than the Company) executing the same and (other than the Company) the due authorization, execution and delivery of all documents by each party thereto.  We have also assumed the conformity of the documents filed with the Commission via the Electronic Data Gathering, Analysis and Retrieval System (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">EDGAR</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), except for required EDGAR formatting changes, to physical copies submitted for our examination.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The opinions in this letter are limited to the existing General Corporation Law of the State of Delaware now in effect.  We express no opinion with respect to any other laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Based upon, and subject to, the foregoing, it is our opinion that the Shares, when issued and sold by the Company in accordance with the terms (including, without limitation, payment and authorization provisions) of the applicable Plan and the applicable form of award agreement thereunder, against the Company&#8217;s receipt of payment therefor (in an amount and type of consideration not less than the par value per Share), and duly registered on the books of the transfer agent and registrar for the Shares in the name or on behalf of the holders thereof, will be validly issued, fully paid and non-assessable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">We consent to the use of this opinion as an exhibit to the Registration Statement and further consent to all references to us, if any, in the Registration Statement, the prospectuses constituting a part thereof and any amendments thereto.  We do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This opinion is intended solely for your use in connection with the issuance and sale of the Shares subject to the Registration Statement and is not to be relied upon for any other purpose.  In providing this letter, we are opining only as to the specific legal issues expressly set forth above, and no opinion shall be inferred as to any other matter or matters.  This opinion is rendered on, and speaks only as of, the date of this letter first written above, and does not address any potential change in facts or law that may occur after the date of this opinion letter.  We assume no obligation to advise you of any fact, circumstance, event or change in the law or the facts that may hereafter be brought to our attention, whether or not such occurrence would affect or modify any of the opinions expressed herein.</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Very truly yours,</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Fenwick &#38; West LLP</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">FENWICK &#38; WEST LLP</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit231-deloitteformsx8.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i641264139f1e469fb68809069aab3ed0_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 23.1</font></div></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 27, 2025, relating to the financial statements of CareDx, Inc., and the effectiveness of CareDx, Inc.&#8217;s internal control over financial reporting, appearing in the Annual Report on Form 10-K of CareDx, Inc. for the year ended December 31, 2024.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Deloitte &#38; Touche LLP</font></div><div><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">San Francisco, California</font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">November 4, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>exhibit993-2025inducementp.htm
<DESCRIPTION>EX-99.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7207a737fce54f2bb04d9e2cbbcd710f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CareDx, Inc.<br>2025 Inducement Plan</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">General</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Plan Purpose</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Company, by means of the Plan, seeks to attract the best available Employees for positions of substantial responsibility by providing a material inducement to individuals entering into employment with the Company or any Affiliate. Awards under the Plan are intended to qualify as &#8220;employment inducement grants&#8221; under the Inducement Listing Rule. The Plan is not a stockholder-approved plan. Capitalized terms not defined elsewhere in the text are defined in Section 13.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Available Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Plan provides for the grant of the following Awards&#58; Nonstatutory Stock Options, SARs, Restricted Stock Awards, RSU Awards, and Performance Awards. Incentive Stock Options may not be granted under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Plan will come into existence on the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Shares Subject to the Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to adjustment in accordance with Section&#160;2(b) and any adjustments as necessary to implement any Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed&#160;350,000 shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Share Reserve Operation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Limit Applies to Common Stock Issued Pursuant to Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  For clarity, the Share Reserve is a limit on the number of shares of Common Stock that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy its obligations to issue shares pursuant to such Awards. For the avoidance of doubt, Awards that by their terms settle in cash shall not reduce the Share Reserve.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.8pt">Reversion of Previously Issued Shares of Common Stock to Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  If any Award is forfeited, expires, terminates, otherwise lapses or is otherwise settled for cash, in whole or in part, without the delivery of Shares, then the Shares covered by such forfeited, expired, terminated or lapsed Award or Award surrendered or settled in cash shall be added back to the Share Reserve and again become available for issuance under the Plan.  For the avoidance of doubt, the following will not be added back to the Share Reserve or again available for issuance under the Plan&#58; (A)&#160;any Shares withheld in respect of taxes, (B)&#160;any Shares tendered or withheld to pay the exercise price of Options, and (C)&#160;any Shares underlying an Award of stock-settled SARs.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Eligibility and Limitations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Eligible Award Recipients</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to the terms of the Plan, only persons who at the time of granting of the Award by the Committee (i) has been hired as an Employee by the Company or any Affiliate and such Award is a material inducement to such person being hired&#59; (ii) has been rehired as an Employee following a bona fide period of interruption with the Company or any Affiliate or (iii) has become an Employee of the Company or any Affiliate in connection with a merger or acquisition to the extent permitted by Nasdaq Listing Rule 5635(c) and the official guidance thereunder.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Specific Award Limitations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Limitations on Nonstatutory Stock Options and SARs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Nonstatutory Stock Options and SARs may not be granted to Employees who are providing Continuous Service unless the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section&#160;409A or unless such Awards otherwise comply with the distribution requirements of Section&#160;409A or is not subject to Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Minimum Vesting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Notwithstanding the Board&#8217;s discretion to determine the vesting schedule applicable to an Award, all Awards, and all portions of Awards, shall be subject to a vesting schedule that provides that the Award shall not vest with respect to any of the covered shares of Common Stock prior to the one year anniversary of the date of grant of the Award (or, if earlier, the date of commencement of employment)&#59; provided, however, that (i) Awards with respect to 5% of the aggregate number of shares subject to the Share Reserve may be granted under the Plan to any one or more Participants (other than Officers) without respect to such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">minimum vesting provisions, (ii) vesting of any Award may accelerate pursuant to Section 6(c)(ii), and (iii) nothing herein shall prohibit the Board from accelerating the vesting of any Award in connection with the termination of a Participant&#8217;s Continuous Service in exchange for a release of claims.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Options and Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each Option and SAR will have such terms and conditions as determined by the Board.  Each Option will be a Nonstatutory Stock Option at the time of grant.  Each SAR will be denominated in shares of Common Stock equivalents.  The terms and conditions of separate Options and SARs need not be identical&#59; provided, however, that each Award Agreement will conform&#160;(through incorporation of provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Term</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  No Option or SAR will be exercisable after the expiration of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Exercise or Strike Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The exercise or strike price of each Option or SAR will not be less than&#160;100% of the Fair Market Value on the date of grant of such Award.  Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than&#160;100% of the Fair Market Value on the date of grant of such Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a corporate transaction and in a manner consistent with the provisions of Sections&#160;409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Exercise Procedure and Payment of Exercise Price for Options</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In order to exercise an Option, the Participant must provide notice of exercise to the Plan Administrator in accordance with the procedures specified in the Award Agreement or otherwise provided by the Company.  The Granting Committee has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment.  The exercise price of an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by one or more of the following methods of payment to the extent set forth in the Award Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">by cash or check, bank draft or money order payable to the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">pursuant to a &#8220;cashless exercise&#8221; program developed under Regulation&#160;T as promulgated by the U.S.&#160;Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the exercise price to the Company from the sales proceeds&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are already owned by the Participant free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (1)&#160;at the time of exercise the Common Stock is publicly traded, (2)&#160;any remaining balance of the exercise price not satisfied by such delivery is paid by the Participant in cash or other permitted form of payment, (3)&#160;such delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock, (4)&#160;any certificated shares are endorsed or accompanied by an executed assignment separate from certificate and (5)&#160;such shares have been held by the Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (1)&#160;such shares used to pay the exercise price will not be exercisable thereafter and (2)&#160;any remaining balance of the exercise price not satisfied by such net exercise is paid by the Participant in cash or other permitted form of payment&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">in any other form of consideration that may be acceptable to the Board and permissible under Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Exercise Procedure and Payment of Appreciation Distribution for SARs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In order to exercise any SAR, the Participant must provide notice of exercise to the Plan Administrator in accordance with the Award Agreement.  The appreciation distribution payable to a Participant upon the exercise of a SAR will not be greater than an amount equal to the excess of (i)&#160;the aggregate Fair Market Value on the date of exercise of a number </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">of shares of Common Stock equal to the number of Common Stock equivalents that are vested and being exercised under such SAR, over (ii)&#160;the strike price of such SAR.  Such appreciation distribution may be paid to the Participant in the form of Common Stock or cash (or any combination of Common Stock and cash) or in any other form of payment, as determined by the Board and specified in the Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Transferability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Options and SARs may not be transferred to third-party financial institutions for value.  The Board may impose such additional limitations on the transferability of an Option or SAR as it determines.  In the absence of any such determination by the Board, the following restrictions on the transferability of Options and SARs will apply, provided that, except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Restrictions on Transfer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will be exercisable during the lifetime of the Participant only by the Participant&#59; provided, however, that the Board may permit transfer of an Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant&#8217;s request, including to a trust if the Participant is considered to be the sole beneficial owner of such trust (as determined under Section&#160;671 of the Code and applicable U.S.&#160;state law) while such Option or SAR is held in such trust, provided that the Participant and the trustee enter into a transfer and other agreements required by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.8pt">Domestic Relations Orders</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable to the Company and subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to a domestic relations order.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.01pt">Vesting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Board may impose such restrictions on or conditions to the vesting and&#47;or exercisability of an Option or SAR as determined by the Board and vesting conditions may include achievement of one or more Performance Goals.  Except as otherwise determined by the Board or provided in the applicable Award Agreement or other written agreement between a Participant and the Company, vesting of Options and SARs will cease upon termination of the Participant&#8217;s Continuous Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Termination of Continuous Service for Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as otherwise determined by the Board or explicitly provided in the Award Agreement or other written agreement between a Participant and the Company, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Options and SARs will terminate and be forfeited immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising any portion (including any vested portion) of such Awards on and after the date of such termination of Continuous Service and the Participant will have no further right, title or interest in such forfeited Award, the shares of Common Stock subject to the forfeited Award, or any consideration in respect of the forfeited Award.  If a Participant is suspended pending investigation of whether his or her Continuous Service shall be terminated for Cause, the Participant&#8217;s rights to exercise an Option or SAR shall be suspended during the investigation period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Post-Termination Exercise Period Following Termination of Continuous Service for Reasons Other than Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to Section&#160;4, if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his or her Option or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company&#59; provided, however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&#160;4(a))&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">3 months following the date of such termination if such termination is a termination without Cause (other than any termination due to the Participant&#8217;s Disability or death)&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">12 months following the date of such termination if such termination is due to the Participant&#8217;s Disability or the Participant&#8217;s death (or if the Participant&#8217;s death occurs following the date of such termination but during the period such Award is otherwise exercisable (as provided in (i)&#160;above)).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following the date of such termination, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or, if earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant will have no further right, title or interest in terminated Award, the shares of Common Stock subject to the terminated Award, or any consideration in respect of the terminated Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Restrictions on Exercise&#59; Extension of Exercisability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  A Participant may not exercise an Option or SAR at any time that the issuance of shares of Common Stock upon such exercise would violate Applicable Law.  Except as otherwise determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company, if a Participant&#8217;s Continuous Service terminates for any reason other than for Cause and, at any time during the last thirty days of the applicable Post-Termination Exercise Period&#58; (i)&#160;the exercise of the Participant&#8217;s Option or SAR would be prohibited solely because the issuance of shares of Common Stock upon such exercise would violate Applicable Law, (ii)&#160;the immediate sale of any shares of Common Stock issued upon such exercise would violate the Company&#8217;s Trading Policy or (iii) the Board has suspended exercisability under Section 7(b), then the applicable Post-Termination Exercise Period will be extended to the last day of the calendar month that commences following the date the Award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period, generally without limitation as to the maximum permitted number of extensions&#59; provided, however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&#160;4(a)).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.01pt">Non-Exempt Employees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  No Option or SAR, whether or not vested, granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of&#160;1938, as amended, will be first exercisable for any shares of Common Stock until at least six months following the date of grant of such Award.  Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic Opportunity Act, any vested portion of such Award may be exercised earlier than six months following the date of grant of such Award in the event of (i)&#160;such Participant&#8217;s death or Disability, (ii)&#160;a corporate transaction in which such Award is not assumed, continued or substituted, (iii)&#160;a Change in Control, or (iv)&#160;such Participant&#8217;s retirement (as such term may be defined in the Award Agreement or another applicable agreement between the Employee and the Company or one of its Affiliates or, in the absence of any such definition, in accordance with the Company&#8217;s then current employment policies and guidelines).  This Section&#160;4(j) is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Whole Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(l)</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Rights as a Stockholder.&#160; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dividends and dividend </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">equivalents</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> may not be paid or&#160;credited to Options or SARs, and a Participant shall have no rights to dividends, dividend equivalents or distributions or any other rights of a stockholder with respect to the Shares subject to an Option or SAR until the Participant has given written notice of the exercise thereof, has paid in full for such Shares and has satisfied the requirements of Section 4(c) or 4(d), as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Awards Other Than Options and Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Restricted Stock Awards and RSU Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Each Restricted Stock Award and RSU Award will have such terms and conditions as determined by the Board&#59; provided, however, that each Restricted Stock Award Agreement and RSU Award Agreement will conform&#160;(through incorporation of the provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Form of Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">RSAs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#58; To the extent consistent with the Company&#8217;s Bylaws, at the Board&#8217;s election, shares of Common Stock subject to a Restricted Stock Award may be (i)&#160;held in book entry form subject to the Company&#8217;s instructions until such shares become vested or any other restrictions lapse, or (ii)&#160;evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board.  Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder of the Company with respect to any shares subject to a Restricted Stock Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">RSUs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#58; A RSU Award represents a Participant&#8217;s right to be issued on a future date the number of shares of Common Stock that is equal to the number of restricted stock units subject to the RSU Award.  As a holder of a RSU Award, a Participant is an unsecured creditor of the Company with respect to the Company&#8217;s unfunded obligation, if any, to issue shares of Common Stock in settlement of such Award and nothing contained in the Plan or any Award Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any other person.  A Participant will not have voting or any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually issued in settlement of a vested RSU Award).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.8pt">Consideration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">RSA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#58; A Restricted Stock Award may be granted in consideration for (A)&#160;cash or check, bank draft or money order payable to the Company, or (B)&#160;any other form of consideration as the Board may determine and permissible under Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">RSU</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#58; Unless otherwise determined by the Board at the time of grant, a RSU Award will be granted in consideration for the Participant&#8217;s services to the Company or an Affiliate, such that the Participant will not be required to make any payment to the Company (other than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common Stock pursuant to the RSU Award.  If, at the time of grant, the Board determines that any consideration must be paid by the Participant (in a form other than the Participant&#8217;s services to the Company or an Affiliate) upon the issuance of any shares of Common Stock in settlement of the RSU Award, such consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.03pt">Vesting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Board may impose such restrictions on or conditions to the vesting of a Restricted Stock Award or RSU Award as determined by the Board, which may include achievement of one or more Performance Goals.  Except as otherwise determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU Awards will cease upon termination of the Participant&#8217;s Continuous Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.57pt">Termination of Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as otherwise determined by the Board or provided in the Award Agreement or other written agreement between a Participant and the Company, if a Participant&#8217;s Continuous Service terminates for any reason, (i)&#160;the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant under his or her Restricted Stock Award that have not vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and (ii)&#160;any portion of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right, title or interest in the RSU Award, the shares of Common Stock issuable pursuant to the RSU Award, or any consideration in respect of the RSU Award&#59; provided, however, that if the Company has a contingent contractual obligation to provide for accelerated vesting of a Participant&#8217;s Restricted Stock Award or RSU Award after termination of the Participant&#8217;s Continuous Service, the unvested portion of such Award subject to potential acceleration shall remain outstanding until the maximum contractual time for determining whether such contingency will occur, and terminate at such time if the contingency has not then occurred.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Dividends and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to a Restricted Stock Award or RSU Award, subject to the same restrictions on transferability and forfeitability as the underlying Award with respect to which such dividends or dividend equivalents are granted and subject to such other terms and conditions as determined by the Board and specified in the Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.57pt">Settlement of RSU Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  A RSU Award may be settled by the issuance of shares of Common Stock or cash (or any combination thereof) or in any other form of payment, as determined by the Board and specified in the RSU Award Agreement.  At the time of grant, the Board may determine to impose such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award in a manner intended to comply with Section 409A, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Adjustments Upon Changes in Common Stock&#59; Other Corporate Events</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Capitalization Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust&#58; (i)&#160;the class(es) and maximum number of shares of Common Stock subject to the Plan and (ii)&#160; the class(es) and number of securities and exercise price, strike price or purchase price of Common Stock subject to outstanding Awards.  The Board shall make such adjustments, and its determination shall be final, binding and conclusive.  Notwithstanding the foregoing, no fractional shares or rights for fractional shares of Common Stock shall be created in order to implement any Capitalization Adjustment.  The Board shall determine an appropriate equivalent benefit, if any, for any fractional shares or rights to fractional shares that might be created by the adjustments referred to in the preceding provisions of this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Dissolution or Liquidation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as otherwise determined by the Board or provided in the Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service, provided, however, that the Board may determine to cause some or all Awards to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">become fully vested, exercisable and&#47;or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  All Awards outstanding on the effective date of a Change in Control shall be treated in the manner described in the definitive agreement evidencing the Change in Control (or, in the event that the Change in Control is not effected pursuant to a definitive agreement to which the Company is party, in the manner determined by the Board, with such determination having final and binding effect on all parties), which agreement or determination need not treat all Awards (or portions thereof) in an identical manner.  Unless an Award Agreement provides otherwise, without limiting the prior sentence, the treatment specified in the transaction agreement or by the Board may include (without limitation) one or more of the following with respect to each outstanding Award&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Awards May Be Assumed</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In the event of a Change in Control, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute similar awards for Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Change in Control), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or the successor&#8217;s parent company, if any), in connection with such Change in Control.  A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of an Award or substitute a similar award for only a portion of an Award, or may choose to assume or continue the Awards held by some, but not all Participants.  The terms of any assumption, continuation or substitution will be set by the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.8pt">Awards Held by Current Participants</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Change in Control (referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Current Participants</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Awards may be exercised) will be accelerated in full to a date prior to the effective time of such Change in Control (contingent upon the effectiveness of the Change in Control) as the Board determines (or, if the Board does not determine such a date, to the date that is five days prior to the effective time of the Change in Control), and such Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Change in Control, and any reacquisition or repurchase rights held by the Company with respect to such Awards will lapse (contingent upon the effectiveness of the Change in Control).  With respect to the vesting of Awards with performance-based vesting that will accelerate upon the occurrence of a Change in Control pursuant to this subsection&#160;(ii) and that have multiple vesting levels depending on the level of performance, unless otherwise provided in the Award Agreement, the vesting of such Awards will accelerate at 100% of the target level upon the occurrence of the Change in Control (or such greater level as determined by the Board).  With respect to the vesting of Awards that will accelerate upon the occurrence of a Change in Control pursuant to this subsection&#160;(ii) and are settled in the form of a cash payment, such cash payment will be made no later than&#160;30&#160;days following the occurrence of the Change in Control or such later date as required to comply with Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.03pt">Awards Held by Persons other than Current Participants</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by persons other than Current Participants, such Awards will terminate if not exercised (if applicable) prior to the occurrence of the Change in Control&#59; provided, however, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.57pt">Payment for Awards in Lieu of Exercise</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Notwithstanding the foregoing, in the event an Award will terminate if not exercised prior to the effective time of a Change in Control, the Board may provide, in its sole discretion, that the holder of such Award may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the effective time, to the excess, if any, of (1)&#160;the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (2)&#160;any exercise price payable by such holder in connection with such exercise&#59; for clarity, an Award may be cancelled without payment of any consideration if the value of such property is equal to or less than the exercise price.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Appointment of Stockholder Representative</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have agreed that the Award will be subject to the terms of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">any agreement governing a Change in Control involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant&#8217;s behalf with respect to any escrow, indemnities and any contingent consideration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">No Restriction on Right to Undertake Transactions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The grant of any Award under the Plan and the issuance of shares pursuant to any Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Administration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Administration by Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in subsection (c) below&#59; provided that, notwithstanding anything to the contrary under the Plan or any delegation by the Board, Awards granted under the Plan must be approved by the Granting Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Powers of Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">To determine from time to time&#58; (1)&#160;which of the persons eligible under the Plan will be granted Awards&#59; (2)&#160;when and how each Award will be granted&#59; (3)&#160;what type or combination of types of Award will be granted&#59; (4)&#160;the provisions of each Award granted (which need not be identical), including the time or times when a person will be permitted to receive an issuance of Common Stock or other payment pursuant to an Award (and whether and to what degree any applicable Performance Goals have been attained)&#59; (5)&#160;the number of shares of Common Stock or cash equivalent with respect to which an Award will be granted to each such person&#59; (6)&#160;the Fair Market Value applicable to an Award&#59; and (7)&#160;the terms of any Award with performance-based vesting that is not valued in whole or in part by reference to, or otherwise based on, the Common Stock, including the amount of cash payment or other property that may be earned and the timing of payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for its administration.  The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it deems necessary or expedient to make the Plan or Award fully effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">To settle all controversies regarding the Plan and Awards granted under it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">To accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding the provisions in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">To prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to&#160;30&#160;days prior to the consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock including any Change in Control, for reasons of administrative convenience or in connection with any other event pursuant to which the Board determines prohibition of exercise is necessary or reasonable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">To suspend or terminate the Plan at any time.  Suspension or termination of the Plan will not Materially Impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.8pt">To amend the Plan in any respect the Board deems necessary or advisable&#59; provided, however, that stockholder approval will be required for any amendment to the extent required by Applicable Law.  Except as provided above, rights under any Award granted before amendment of the Plan will not be Materially Impaired by any amendment of the Plan unless (1)&#160;the Company requests the consent of the affected Participant, and (2)&#160;such Participant consents in writing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.03pt">To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion&#59; provided however, that, (1) the Board shall not, without stockholder approval, reduce the exercise or strike price of an Option or SAR (other than in connection with a Capitalization Adjustment) and, at any time when the exercise or strike price of an Option or SAR is above the Fair Market Value of a share of Common Stock, the Board shall not cancel and re-grant or exchange such Option or SAR for a new Award with a lower (or no) purchase price or for cash, and (2) a Participant&#8217;s rights under any Award will not be Materially Impaired by any such amendment unless (A)&#160;the Company requests the consent of the affected Participant, and (B)&#160;such Participant consents in writing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">To adopt such procedures and sub-plans as are necessary or appropriate to permit and facilitate participation in the Plan by, or take advantage of specific tax treatment for Awards granted to, Employees who are non-U.S.&#160;nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement to ensure or facilitate compliance with the laws of the relevant non-U.S.&#160;jurisdiction).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Delegation to Committee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">General</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to 7(a) and the Inducement Listing Rules, the Board may delegate some or all of the administration of the Plan to a Committee or Committees.  If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to another Committee or a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board.  Each Committee may retain the authority to concurrently administer the Plan with the Committee or subcommittee to which it has delegated its authority hereunder and may, at any time, revest in such Committee some or all of the powers previously delegated.  The Board will retain the authority to concurrently administer the Plan with any Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.8pt">Rule&#160;16b-3 Compliance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  To the extent an Award is intended to qualify for the exemption from Section&#160;16(b) of the Exchange Act that is available under Rule&#160;16b-3 of the Exchange Act, the Award will be granted by a Committee that consists solely of two or more Non-Employee Directors (which Committee will also satisfy the Inducement Listing Rules), as determined under Rule&#160;16b-3(b)(3) of the Exchange Act, and, thereafter, any action establishing or modifying the terms of the Award will be approved by the Board or a Committee meeting such requirements to the extent necessary for such exemption to remain available.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Effect of Board&#8217;s Decision</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  All determinations, interpretations and constructions made by the Board or any Committee in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Tax Withholding</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Withholding Authorization</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from payroll and any other amounts payable to such Participant, and otherwise agrees to make adequate provision for (including), any sums required to satisfy any U.S.&#160;and&#47;or non-U.S.&#160;federal, state, or local tax or social insurance contribution withholding obligations of the Company or an Affiliate, if any, which arise in connection with the exercise, vesting or settlement of such Award, as applicable.  Accordingly, a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Satisfaction of Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any U.S.&#160;and&#47;or non-U.S.&#160;federal, state or local tax or social insurance withholding obligation relating to an Award by any of the following means or by a combination of such means&#58; (i)&#160;causing the Participant to tender a cash payment&#59; (ii)&#160;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award&#59; (iii)&#160;withholding cash from an Award settled in cash&#59; (iv)&#160;withholding payment from any amounts otherwise </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">payable to the Participant&#59; (v)&#160;by allowing a Participant to effectuate a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation&#160;T as promulgated by the U.S.&#160;Federal Reserve Board or (vi)&#160;by such other method as may be set forth in the Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">No Obligation to Notify or Minimize Taxes&#59; No Liability to Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as required by Applicable Law, the Company has no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Award.  Furthermore, the Company has no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised.  The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will not be liable to any holder of an Award for any adverse tax consequences to such holder in connection with an Award.  As a condition to accepting an Award under the Plan, each Participant (i)&#160;agrees not to make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from such Award or other Company compensation and (ii)&#160;acknowledges that such Participant was advised to consult with his or her own personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or knowingly and voluntarily declined to do so.  Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt from Section&#160;409A only if the exercise or strike price is at least equal to the &#8220;fair market value&#8221; of the Common Stock on the date of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation associated with the Award.  Additionally, as a condition to accepting an Option or SAR granted under the Plan, each Participant agrees not to make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the U.S.&#160;Internal Revenue Service asserts that such exercise price or strike price is less than the &#8220;fair market value&#8221; of the Common Stock on the date of grant as subsequently determined by the U.S.&#160;Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Withholding Indemnification</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  As a condition to accepting an Award under the Plan, in the event that the amount of the Company&#8217;s and&#47;or its Affiliate&#8217;s withholding obligation in connection with such Award was greater than the amount actually withheld by the Company and&#47;or its Affiliates, each Participant agrees to indemnify and hold the Company and&#47;or its Affiliates harmless from any failure by the Company and&#47;or its Affiliates to withhold the proper amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Source of Shares&#59; Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.  No fractional shares of Common Stock will be issued or delivered pursuant to this Plan or any Award.  The Board may determine whether cash, other Awards or other securities or property will be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto will be forfeited or otherwise eliminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Use of Proceeds from Sales of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">Corporate Action Constituting Grant of Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Granting Committee, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant.  In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until (i)&#160;such Participant has satisfied all requirements for exercise of the Award pursuant to its terms, if applicable, and (ii)&#160;the issuance of the Common Stock subject to such Award is reflected in the records of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.91pt">No Employment or Other Service Rights</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or affect the right of the Company or an Affiliate to terminate at will and without regard to any future vesting opportunity that a Participant may have with respect to any Award, &#160;the employment or Continuous Service of a Participant with or without notice and with or without cause.  Further, nothing in the Plan, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">any Award Agreement or any other instrument executed thereunder or in connection with any Award will constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or service or confer any right or benefit under the Award or the Plan unless such right or benefit has specifically accrued under the terms of the Award Agreement and&#47;or Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.01pt">Change in Time Commitment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if an Employee of the Company has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law and without the affected Participant&#8217;s consent, to (i)&#160;make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (ii)&#160;in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award.  In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Execution of Additional Documents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents or instruments necessary or desirable, as determined in the Plan Administrator&#8217;s sole discretion, to carry out the purposes or intent of the Award, or facilitate compliance with securities and&#47;or other regulatory requirements, in each case at the Plan Administrator&#8217;s request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Electronic Delivery and Participation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Any reference herein or in an Award Agreement to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).  By accepting any Award, the Participant consents to receive documents by electronic delivery and to participate in the Plan through any on-line electronic system established and maintained by the Plan Administrator or another third party selected by the Plan Administrator.  The form of delivery of any Common Stock (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Clawback&#47;Recovery</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law and any clawback policy that the Company otherwise adopts, to the extent applicable and permissible under Applicable Law.  In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause.  No recovery of compensation under such a clawback policy will be an event giving rise to a Participant&#8217;s right to voluntarily terminate employment upon a &#8220;resignation for good reason,&#8221; or for a &#8220;constructive termination&#8221; or any similar term under any plan of or agreement with the Company or any of its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.01pt">Securities Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  A Participant will not be issued any shares in respect of an Award unless either (i)&#160;the shares are registered under the Securities Act&#59; or (ii)&#160;the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act.  Each Award also must comply with other Applicable Law governing the Award, and a Participant will not receive such shares if the Company determines that such receipt would not be in material compliance with Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Transfer or Assignment of Awards&#59; Issued Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as otherwise determined by the Board or expressly provided in the Plan or the form of Award Agreement, Awards granted under the Plan may not be transferred or assigned by the Participant.  After the vested shares subject to an Award have been issued, or in the case of Restricted Stock Awards and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein, the terms of the Trading Policy and Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:26.57pt">Effect on Other Employee Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  The value of any Award granted under the Plan, as determined upon grant, vesting or settlement, shall not be included as compensation, earnings, salaries, or other similar terms used when calculating any Participant&#8217;s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides.  The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.01pt">Deferrals</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants.  Deferrals will be made in accordance with the requirements of Section&#160;409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&#160;409A, and, to the extent not so exempt, in compliance with the requirements of Section&#160;409A.  If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section&#160;409A, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&#160;409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement.  Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section&#160;409A is a &#8220;specified employee&#8221; for purposes of Section&#160;409A, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section&#160;409A without regard to alternative definitions thereunder) will be issued or paid before the date that is six months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section&#160;409A, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.34pt">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to conflict of law principles that would result in any application of any law other than the law of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.78pt">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.  As a condition of receipt of any Award, each Participant explicitly and unambiguously acknowledges that the Company and its Affiliates will process certain personal information about the Participant in accordance with the provisions of the Company&#8217;s privacy notice, a copy of which can be obtained by the Participant by contacting his or her local human resources representative.  Such personal information may include, but is not limited to, the Participant&#8217;s name, home address, email address and telephone number, date of birth, social security or insurance number, passport number or other identification number, salary, nationality, job title, any shares or directorships held in the Company, and details of all Awards or any other entitlement to shares of Common Stock awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Data</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), for the exclusive purpose of implementing, administering and managing the Plan.  In certain jurisdictions, the Participant&#8217;s consent is required in order for the parties to process Participant&#8217;s personal information for the purpose of implementing, administering and managing Participant&#8217;s participation in the Plan pursuant to and in accordance with his or her Award Agreement.  Where such consent is required and without limiting any other specific consent provided by the Participant, including in any consent provided in a separate document, the Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant&#8217;s personal data as described herein and any other applicable Award grant materials by and among, as applicable, the Company or any of its Affiliates for the exclusive purpose of implementing, administering and managing the Participant&#8217;s participation in the Plan.  The Participant understands that Data will be transferred to a stock plan service provider as may be selected by the Company from time-to-time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Designated Broker</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), which is assisting the Company with the implementation, administration and management of the Plan.  The Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country of operation may have different data privacy laws and protections than the Participant&#8217;s country.  The Participant understands that if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative.  The Participant authorizes (where such authorization is required) the Company, the Designated Broker and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing his or her participation in the Plan.  The Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan.  The Participant understands that if he or she resides outside the United States, he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or, where applicable, refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative.  Further, the Participant understands that where his or her consent is required by applicable law, he or she is providing the consents on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, his or her status as an Employee, Consultant or Director and career with the Company and its Affiliates will not be adversely affected&#59; the only adverse consequence of refusing or withdrawing the Participant&#8217;s consent is that the Company would not be able to grant Awards to the Participant or administer or maintain such Awards.  Therefore, the Participant understands that refusing or withdrawing his or her consent may affect the Participant&#8217;s ability to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">participate in the Plan.  For more information on the consequences of the Participant&#8217;s refusal to consent or withdrawal of consent, the Participant understands that he or she may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The Company will seek to obtain from each regulatory commission or agency, as may be deemed necessary, having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Awards&#59; provided, however, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award.  If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Awards unless and until such authority is obtained.  A Participant is not eligible for the grant of an Award or the subsequent issuance of Common Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If all or any part of the Plan or any Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid.  Any Section of the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Board may suspend or terminate the Plan at any time.  No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Definitions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As used in the Plan, the following definitions apply to the capitalized terms indicated below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 5605(a)(2) of Nasdaq Listing Rules.  The Board may determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the Code and any applicable U.S.&#160;or non-U.S.&#160;securities, federal, state, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including under the authority of any applicable self-regulating organization such as The Nasdaq Stock Market LLC, the New York Stock Exchange or the Financial Industry Regulatory Authority, Inc.).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any right to receive Common Stock, cash or other property granted under the Plan (including a Nonstatutory Stock Option, a Restricted Stock Award, a RSU Award, or a SAR).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award.  The Award Agreement generally consists of the Grant Notice and the agreement containing the written summary of the general terms and conditions applicable to the Award and which is provided to a Participant along with the Grant Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the board of directors of the Company (or its designee).  Any decision or determination made by the Board shall be a decision or determination that is made in the sole discretion of the Board (or its designee), and such decision or determination shall be final and binding on all Participants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Capitalization Adjustment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic&#160;718 (or any successor thereto).  Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; has the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events&#58; (i)&#160;the Participant&#8217;s theft, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or intentional falsification of any Company or Affiliate documents or records&#59; (ii)&#160;the Participant&#8217;s material failure to abide by the Company&#8217;s Code of Conduct or other policies (including, without limitation, policies relating to confidentiality and reasonable workplace conduct and policies of any Affiliate, as applicable)&#59; (iii)&#160;the Participant&#8217;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of the Company or any of its Affiliates (including, without limitation, the Participant&#8217;s improper use or disclosure of Company or Affiliate confidential or proprietary information)&#59; (iv)&#160;any intentional act by the Participant which has a material detrimental effect on the Company&#8217;s or its Affiliate&#8217;s reputation or business&#59; (v)&#160;the Participant&#8217;s repeated failure or inability to perform any reasonable assigned duties after written notice from the Company (or its Affiliate, as applicable) of, and a reasonable opportunity to cure, such failure or inability&#59; (vi)&#160;any material breach by the Participant of any employment or service agreement between the Participant and the Company (or its Affiliate, as applicable), which breach is not cured pursuant to the terms of such agreement&#59; or (vii)&#160;the Participant&#8217;s conviction (including any plea of guilty or </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Participant&#8217;s ability to perform his or her duties with the Company (or its Affiliate, as applicable).  The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who are executive officers of the Company or members of the Board and by the Company&#8217;s Chief Executive Officer or his or her designee with respect to all other Participants.  Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events&#59; provided, however, to the extent necessary to avoid adverse personal income tax consequences to the Participant in connection with an Award, also constitutes a Section&#160;409A Change in Control&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than&#160;50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.  Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A)&#160;on account of the acquisition of securities of the Company directly from the Company, (B)&#160;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&#160;solely because the level of Ownership held by any Exchange Act Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Subject Person</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A)&#160;outstanding voting securities representing more than&#160;50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&#160;more than&#160;50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">the stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company shall otherwise occur, except for a liquidation into a parent corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, at least&#160;50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">during any period of 12 consecutive months, individuals who, on the date the Plan is adopted by the Compensation Committee, are members of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Incumbent Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) cease for any reason to constitute at least a majority of the members of the Board&#59; provided, however, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board and that no individual initially elected or nominated as a member of the Board as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Proxy Contest</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), including by reason of any agreement intended to avoid or settle any Proxy Contest, shall be considered to be a member of the Incumbent Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing or any other provision of this Plan, (A)&#160;the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&#160;the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Awards subject to such agreement&#59; provided, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the U.S.&#160;Internal Revenue Code of&#160;1986, as amended, including any applicable regulations and guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the Compensation Committee and any other committee of one or more Directors to whom authority has been delegated by the Board or Compensation Committee in accordance with the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the common stock, par value $0.001 per share, of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means CareDx, Inc., a Delaware corporation, and any successor corporation thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the Compensation and Human Capital Committee of the Board. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Consultant</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any person, including an advisor, who is (i)&#160;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&#160;serving as a member of the board of directors of an Affiliate and is compensated for such services.  However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan.  Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Registration Statement on Form&#160;S-8 under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated.  A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service&#59; provided, however, that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate.  For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Continuous Service.  To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&#160;any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&#160;transfers between the Company, an Affiliate, or their successors.  Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.  In addition, to the extent required for exemption from or compliance with Section&#160;409A, the determination of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under U.S.&#160;Treasury Regulation&#160;Section&#160;1.409A-1(h) (without regard to any alternative definition thereunder).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">determine</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">determined</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means as determined by the Board or the Committee (or its designee) in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Director</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a member of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Disability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity after accounting for reasonable accommodations (if applicable and required by Applicable Law) by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than&#160;12&#160;months, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.45pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;&#160;means the date on which the Company&#8217;s Board approved the adoption of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any person employed by the Company or an Affiliate.  Service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.  However, for the avoidance of doubt, although a person who is an Employee also may be a Director, a person who already is serving as a Director prior to becoming an Employee will not be eligible to be granted an Award under the Plan unless permitted under the Inducement Listing Rule. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Employer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the Company or the Affiliate that employs the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Entity</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a corporation, partnership, limited liability company or other entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.12pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the U.S.&#160;Securities Exchange Act of&#160;1934, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Exchange Act Person</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section&#160;13(d) or&#160;14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i)&#160;the Company or any Subsidiary of the Company, (ii)&#160;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&#160;an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv)&#160;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company&#59; or (v)&#160;any natural person, Entity or &#8220;group&#8221; (within the meaning of Section&#160;13(d) or&#160;14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than&#160;50% of the combined voting power of the Company&#8217;s then outstanding securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, as of any date, unless otherwise determined by the Board, the value of the Common Stock (as determined on a per share or aggregate basis, as applicable) determined as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">if the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">in the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections&#160;409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any&#58; (a)&#160;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature&#59; (b)&#160;U.S.&#160;or non-U.S.&#160;federal, state, local, municipal, or other government&#59; (c)&#160;governmental or regulatory body, or quasi-governmental body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any tax authority) or other body exercising similar powers or authority&#59; or (d)&#160;self-regulatory organization (including The Nasdaq Stock Market LLC, the New York Stock Exchange, and the Financial Industry Regulatory Authority, Inc.).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Granting Committee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the Compensation Committee or a majority of the Company&#8217;s &#8220;Independent Directors&#8221; (as defined in the Nasdaq Listing Rules)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ab)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the notice provided to a Participant that he or she has been granted an Award under the Plan and which includes the name of the Participant, the type of Award, the date of grant of the Award, number of shares of Common Stock subject to the Award or potential cash payment right, (if any), the vesting schedule for the Award (if any) and other key terms applicable to the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ac)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:19.91pt">&#8239;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an option that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section&#160;422 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ad)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inducement Listing Rule</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Nasdaq Listing Rule 5635(c) and the related guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ae)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Materially Impair</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any amendment to the terms of the Award that materially adversely affects the Participant&#8217;s rights under the Award.  A Participant&#8217;s rights under an Award will not be deemed to have been Materially Impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights.  For example, the following types of amendments to the terms of an Award do not Materially Impair the Participant&#8217;s rights under the Award&#58; (i)&#160;imposition of reasonable restrictions on the minimum number of shares subject to an Option that may be exercised&#59; (ii)&#160;to clarify the manner of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section&#160;409A&#59; or (iii)&#160;to comply with other Applicable Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(af)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a Director who either (i)&#160;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item&#160;404(a) of Regulation&#160;S-K promulgated pursuant to the Securities Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Regulation&#160;S-K</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item&#160;404(a) of Regulation&#160;S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&#160;404(b) of Regulation&#160;S-K&#59; or (ii)&#160;is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule&#160;16b-3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ag)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Nonstatutory Stock Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means any option granted pursuant to Section&#160;4 of the Plan that does not qualify as an Incentive Stock Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ah)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Officer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ai)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(aj)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Own,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Owned,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Owner,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Ownership</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means that a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ak)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an Employee to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(al)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Performance Criteria</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period.  The Performance Criteria that will be used to establish such Performance Goals may include (but is not limited to) any one of, or combination of, the following as determined by the Board&#58; earnings (including earnings per share and net earnings)&#59; earnings before interest, taxes and depreciation&#59; earnings before interest, taxes, depreciation and amortization&#59; total stockholder return&#59; return on equity or average stockholder&#8217;s equity&#59; return on assets, investment, or capital employed&#59; stock price&#59; margin (including gross margin)&#59; income (before or after taxes)&#59; operating income&#59; operating income after taxes&#59; pre-tax profit&#59; operating cash flow&#59; sales or revenue targets&#59; increases in revenue or product revenue&#59; expenses and cost reduction goals&#59; improvement in or attainment of working capital levels&#59; economic value added (or an equivalent metric)&#59; market share&#59; cash flow&#59; cash flow per share&#59; share price performance&#59; debt reduction&#59; customer satisfaction&#59; stockholders&#8217; equity&#59; capital expenditures&#59; debt levels&#59; operating profit or net operating profit&#59; workforce diversity&#59; growth of net income or operating income&#59; billings&#59; pre-clinical development related compound goals&#59; financing&#59; regulatory milestones, including approval of a compound&#59; stockholder liquidity&#59; corporate governance and compliance&#59; product commercialization&#59; intellectual property&#59; personnel matters&#59; progress of internal research or clinical programs&#59; progress of partnered programs&#59; partner satisfaction&#59; budget management&#59; clinical achievements&#59; completing phases of a clinical study (including the treatment phase)&#59; announcing or presenting preliminary or final data from clinical studies&#59; in each case, whether on particular timelines or generally&#59; timely completion of clinical trials&#59; submission of INDs and NDAs and other regulatory achievements&#59; partner or collaborator achievements&#59; internal controls, including those related to the Sarbanes-Oxley Act of&#160;2002&#59; research progress, including the development of programs&#59; investor relations, analysts and communication&#59; manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities)&#59; strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property&#59; establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#8217;s products (including with group purchasing organizations, distributors and other vendors))&#59; supply chain achievements (including establishing relationships with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#8217;s products)&#59; co-development, co-marketing, profit sharing, joint venture or other similar arrangements&#59; individual performance goals&#59; corporate development and planning goals&#59; and other measures of performance selected by the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(am)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria.  Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices.  Unless specified otherwise by the Board (i)&#160;in the Award Agreement at the time the Award is granted or (ii)&#160;in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows&#58; (1)&#160;to exclude restructuring and&#47;or other nonrecurring charges&#59; (2)&#160;to exclude exchange rate effects&#59; (3)&#160;to exclude the effects of changes to generally accepted accounting principles&#59; (4)&#160;to exclude the effects of any statutory adjustments to corporate tax rates&#59; (5)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles&#59; (6)&#160;to exclude the dilutive effects of acquisitions or joint ventures&#59; (7)&#160;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture&#59; (8)&#160;to exclude the effect of any change in the outstanding shares of Common Stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends&#59; (9)&#160;to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans&#59; (10)&#160;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles&#59; and (11)&#160;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles.  In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period.  Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(an)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to vesting or exercise of an Award.  Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ao)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.34pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means this CareDx, Inc. 2025 Inducement Plan, as amended from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ap)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Plan Administrator</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the person, persons, and&#47;or third-party administrator designated by the Company to administer the day-to-day operations of the Plan and the Company&#8217;s other equity incentive programs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(aq)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Post-Termination Exercise Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the period following termination of a Participant&#8217;s Continuous Service within which an Option or SAR is exercisable, as specified in Section&#160;4(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ar)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">RSA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an Award of shares of Common Stock granted pursuant to the terms and conditions of Section&#160;5(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(as)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:20.45pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant.  The Restricted Stock Award Agreement includes the Grant Notice for the Restricted Stock Award and the agreement containing the written summary of the general terms and conditions applicable to the Restricted Stock Award and which is provided to a Participant along with the Grant Notice.  Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(at)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">RSU Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">RSU</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means an Award of restricted stock units representing the right to receive an issuance of shares of Common Stock which is granted pursuant to the terms and conditions of Section&#160;5(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(au)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">RSU Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a written agreement between the Company and a holder of a RSU Award evidencing the terms and conditions of a RSU Award.  The RSU Award Agreement includes the Grant Notice for the RSU Award and the agreement containing the written summary of the general terms and conditions applicable to the RSU Award and which is provided to a Participant along with the Grant Notice.  Each RSU Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(av)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Rule&#160;16b-3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Rule&#160;16b-3 promulgated under the Exchange Act or any successor to Rule&#160;16b-3, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(aw)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.12pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Rule&#160;405</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Rule&#160;405 promulgated under the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ax)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means Section&#160;409A of the Code and the regulations and other guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ay)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Section&#160;409A Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the Company&#8217;s assets, as provided in Section&#160;409A(a)(2)(A)(v) of the Code and Treasury Regulations&#160;Section&#160;1.409A-3(i)(5) (without regard to any alternative definition thereunder).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(az)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the U.S.&#160;Securities Act of&#160;1933, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(ba)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Share</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a share of Common Stock, as adjusted in accordance with Section&#160;6 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(bb)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.22pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the number of shares available for issuance under the Plan as set forth in Section&#160;2(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(bc)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.35pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">SAR</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&#160;4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(bd)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.22pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Company, (i)&#160;any corporation of which more than&#160;50% of the outstanding Common Stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&#160;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than&#160;50%.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(be)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.35pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Trading Policy</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; means the Company&#8217;s policy permitting certain individuals to sell Company shares only during certain &#8220;window&#8221; periods and&#47;or otherwise restricts the ability of certain individuals to transfer or encumber Company shares, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Adopted by the Compensation Committee on October 22, 2025<br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>fenwicklogoa.jpg
<TEXT>
begin 644 fenwicklogoa.jpg
M_]C_X  02D9)1@ ! 0$!] 'T  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #5#48# 2(  A$! Q$!_\0
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MJKJ2K L>"*VIT*M:_LXN5NRN95*M.E_$DEZNQUE%<C_PMGPC_P!!VU_[Z/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 AZ5^8.M?\ (8O_ /KO)_Z$:_3X]*_,'6O^0Q?_
M /7>3_T(U^M< ?'B?2/_ +<?F/&_PX?_ +>_]M*=%%%?L)^5!1110 4444 %
M%%% 'IW[-7_):?#O^_+_ .BGK[]KX"_9J_Y+3X=_WY?_ $4]??M?A?'?_(QI
M_P"!?^E2/V7@S_<)_P"-_DCX9_:Q_P"2M3?]>L?_ *$U>-5[+^UC_P E:F_Z
M]8__ $)J\:K]7R+_ )%F'_PH_-,Y_P"1C7_Q,****]T\4**** "BBB@ HHHH
M _1/X*?\DST/_KB*[BN'^"G_ "3/0_\ KB*[BOY4S#_?*W^)_F?TM@?]UI?X
M5^1^;WQ3_P"2AZ]_U\G^0KE:ZKXI_P#)0]>_Z^3_ "%<K7]/X+_=J7^%?DC^
M=,7_ +Q4_P 3_,*]:_9^^,4WPV\0K:7<A;1;QPLRD_ZLG@,/TS[5Y+12QF#I
M8^A+#UU>,OZO\AX3%5<%6C7HNTD?J+:7<-]:Q7%O(LL$J!T=3D,I&0:FKY5_
M9;^-GE-'X2UF<D,?]#G=NG^P?Z?2OJJOYJS;+*N4XJ6'J_)]UW/Z"RS,:69X
M>->G\UV?8****\8]4K:E_P @^Y_ZYM_*OS,\0?\ (>U+_KYE_P#0S7Z9ZE_R
M#[G_ *YM_*OS,\0?\A[4O^OF7_T,U^N< [XC_MW]3\OXVVH?]O?H4****_7S
M\L/TU\(_\BIHO_7E#_Z+6O(/VO/#W]I?#J/4$3=-9W"\^B'.[^0KU_PC_P B
MIHO_ %Y0_P#HM:S/BAX?_P"$I\ ZWI@7=)/;,J>S8X-?S!E^)^IYG3K]%/7T
MOJ?T7C</]:RZ='O'\;:'YNT4^>(PS21GJC%?R-,K^GMS^==CT/X!:^?#OQ5T
M.8MMCFF%NY]%8C/\J_0=6#*".A&17Y>6-Y+I]Y#<P-LFB8.K>A%?I=X4U5-;
M\-:;?1G<DT"L#Z\8_I7XWQYA>6K1Q*ZIQ?RU_4_6."\1S4JN'?1I_?I^AK44
M45^4GZ4>+_M5^+#X=^&SVD4OEW&HR")2#S@$%OTS7PY7O7[7GBTZQXY@TF-P
M8-/BPZYZ2$G/Z$5X+7]$\)X+ZGE<&UK/WG\]OP/PCB?%_6LQFD](>ZOEO^(5
MZ;^SMXM'A/XG:;)*^RVN28).>N00OZD5YE4UE=/8WMO<QG#PR+(I]P<BOIL9
MAXXO#U,/+:2:^\^>PE>6%KPKQWBTS]1:*YSX>>(H_%7@O2-2C?S#+;IO;.?G
M"@-^N:Z.OY5JTY4:DJ<]T[?<?TI3J1JP52.S5PKQ+]K3Q"-)^&9LT?$U[.L9
M7U3#9_I7MM?(7[9OB W/B;2=)1OEMH6>1?=MI'Z9KZ7AC"_6LUHQ>T?>^[7\
MSY_B+$?5LLJRZO3[SYQHHHK^D3\ /3OV</#_ /PD/Q9TA2N]+4FZ8=L*1_C7
MWX!@8%?*W[%WAL23:WK;KAHMD$;$=0V2?_017U57X!QGBO;YFZ:V@DOGO^I^
MX<)X;V.7*H]YMO\ 3]#XD_:Y_P"2EK_UP']*\/KW#]KG_DI:_P#7 ?TKP^OU
M_(/^15A_\*/RO//^1E7_ ,05]7_L4_\ (,\0_P#79?\ T$5\H5]7_L4_\@SQ
M#_UV7_T$5YO%W_(GJ_+\T>APO_R-*?S_ "9].4445_.Q^[A4-U=PV-O)/<2+
M##&-S.YP *9J&H6^E6,UY=2K#;PJ7>1S@ 5\4?'CX_W?C^^ETO2)GM]!C)'R
MY!G]S[>WO7T639+7SFMR4](K>7;_ ()X6;9O1RFCSU-9/9=_^ >E_%;]K2WT
MQY=/\)HMW."4>]D^XI_V1SG]*^9_$_CG7/&-TT^K:C/=LQSL9SL7Z#H*P:*_
M>\MR3!97!*A#WOYGJW_7D?BF89QB\RDW6G[O9;?UZA1117O'B!1110!J:#XG
MU7PQ=+<:7?SV4@.<PR%<_7'6OHKX5_M;SI/#I_BZ-7A.%6_B !7_ 'E_KFOF
M&BO&S'*,'F<''$03??JOF>O@,UQ>734J$].W1_(_3_2-8L]=L(KVPN$NK64;
MDDC.015RO@3X+_&[4?AAJZ1S2/<Z)*P$UL3G9_M+[_X5]T^'M?LO$^CVVI:?
M,LUK.@96!_2OP7/,BKY-5L_>IO:7Z/S/VK)\ZHYM2NM)K=?JO(OR_P"J?Z&O
MS:^(W_(\ZW_U\M7Z2R_ZI_H:_-KXC?\ (\ZW_P!?+5]9P%_'K^B_,^8XU_@4
M?5_D<Y1117[.?DI^AGP$_P"2.^%/^O,?^A&N_K@/@)_R1WPI_P!>8_\ 0C7?
MU_*N9?[]7_QR_-G]*9?_ +G1_P ,?R04=**\"_:)^/D7A"RFT'0KA7UJ4;99
M4.1 IZ]/XL9IY?E]?,L1'#T%=O[DN[#'8VCE]!UZ[LE^/DBM^T1^T%%X9MIO
M#V@3++J<J[9YU/$ ]O>OCR65YY&DD8N['+,QR2:=<7$MW/)-,[22R,69V.22
M>IJ.OZ,RC**&3X=4:6K>[ZM_ULC\%S7-*V:U_:U-$MEV05+:VLM[<1P01M+-
M(P5449)--AADN)DBB1I)'(5549))Z 5]@_LZ?L_CPO'%XB\00J^IR*&M[=AG
MR0>Y_P!K^6:,XS>AE&'=:J[R>RZM_P"7=AE65ULTKJE3T75]E_6Q9_9\_9[B
M\'V\.O:]"'UEQNBMW&1 /7_>_EBO?J**_G/,,PKYE7>(Q#NW]R79'[U@<#1R
M^BJ%!62_'S84445YIWA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <MXQ^*/A/X?/ GB/7K+1VGYC%U)MW?2N;_X:9^%G_0]:/\ ]_\
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MM>2_ #Q]X=OOAMX2TN/Q!IUQJPT^%6M%NT:;<$&05SG.:]:I %%%% !1110
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M8Z-]'_F?LM/A# 3A&3E+5=U_D?!__#+WCW_H%C_OXO\ C1_PR]X]_P"@6/\
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M9E_+#[G_ )A_J=E_\TOO7^1\'_\ #+WCW_H%C_OXO^-'_#+WCW_H%C_OXO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'1[_ ,$R1CS&M65E!_BVYQ_*I/ _[*.N_&ZRMO%?COQ)>V0ND26ULK;!,<8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW5Q_K+B2T0R,<8R6QG-+U ^,_@]<W7[3G[1,?C'5I[;3[?3662*QW?,X7A5
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M[1@DDO16OZL****]H\@^LOV<?V?8;."V\4:_&D\\@$EI;Y!5 >C'W_QKZ8
M&!P*^7?V4_C$&0>$M6G.X9-E+(>OJF?S_*OJ.OYQXG^NK,9K&._\O;EZ6_7S
M/WWAWZH\!!X16[][];_UL%%%%?)'TP4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9"JG*/GYF7@[@>.GI7Z"UR_C+X9>&/B!;M#KVCVVH*RE"SKA\'K\PP?UI)]
M/%M:_;S^&MIIDDNG3WVH7@4E+<VKQ@MC@;B,5X]\!O#/B']H?XZO\2-<M9+?
M2K.421EP0K[1M1!GKA>I'<5]*:7^R9\*]'O8[NV\*PK-'G:7GE<?D6(KU/3-
M*L]%LX[2PM8;.VC&%BA0*H_ 4[I; ?%W[;G_ "5KP1_OK_-:^T-&_P"0/8_]
M<(__ $$5RWC7X-^$?B'JUEJ6OZ2+^]LSF"0RNNS\%(':NRAA2WA2*,;410JC
MT X%)L#Y&_X*#_\ (O>&O^OH?UKZ/^$O_)-?#?\ UY)_*CQ_\*O"_P 4+>V@
M\2Z8-2BMWWQ*9'3:?7Y2*Z+2=*M=$TVVL+*+R;6W01Q1Y)VJ.@R:+Z6 \Y_:
M:_Y(=XI_ZX+_ .AK7E_[!G_)%+[_ *^9/YM7T;XE\-:=XOT2ZTC5K<76GW*[
M982Q7<,YZ@@]JS/ GPV\._#717TGP[IXT^P=B[1"1GR3G/+$GN:+Z6 ^.?V2
M?^3F?%7TE_DU-_:UL[[X;_'[0?&\MJ]SIKE9-V,J"/E*Y[' )KZV\)_!/P;X
M(\2W6OZ+HZV>K76?-N!,[;L]>"2.]=)XC\+:3XNTV2PUBP@O[5Q@I,@./H>H
M_"G?6X6/"!^WC\,#IGGFYOA>;-WV7[))][^[NQC\:^8?VF_B5XF^-FG6?B3^
MQI=.\&6DS1V;3 AG<X!;/&0<KV[5]GZ=^RE\+=*U$7MOX5A6X!R"\TC+_P!\
MEB*[O7O 7A_Q+X=?0M0TJVFTEAM^RJ@11],8Q^%%TM@.'_9O^*NA?$OX?V4>
MC2RO+I4,5I=++$5VN$'0GK^%>L5R'P[^$WA;X4VEW;>%],&F0W3B291*[[F
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MXU7]/9%_R+,/_A1_.V<_\C&O_B8445[=\#_@%:?%70+G4+B_DM6BF,051UP
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M0JJTHEC3[^?2[Z"[MI&BGA<.CJ<$$5]^? [XJ0?$[PE%-(ZC5+<!+J,'G/\
M>QZ'FOS[KM/A/\1[KX9^+;;4XBSVI.VXA!^^G?\ &OGN(\ECF^%]Q?O(ZQ_R
M^?YGNY!FSRO$^^_W<M'_ )_(_1>BL_0-<M/$FCVNI64JS6UP@=64YK0K^<Y1
ME"3C)6:/WF,E.*E%W3"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK'7QCH+:O_92Z
MUIYU3./L0ND\[/ILSG]*V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]
M*_,'6O\ D,7_ /UWD_\ 0C7Z?'I7Y@ZU_P AB_\ ^N\G_H1K]:X ^/$^D?\
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M^E>'U[A^US_R4M?^N _I7A]?TWD'_(JP_P#A1_/&>?\ (RK_ .(*^K_V*?\
MD&>(?^NR_P#H(KY0KZO_ &*?^09XA_Z[+_Z"*\WB[_D3U?E^:/0X7_Y&E/Y_
MDSZ<KSSX[^"?^$Y^'.I6D8S<P)]HB/?*_,0/KC%>ATC*&4J1D$8(-?@&%Q$\
M)7A7I[Q::^1^WXBA#$T949[231^6\D;0R/&ZE74E64]013:]F_:6^%3^!O%;
MZG:1'^R=0<NK <)(>2I^IR:\9K^HL#C*6/PT,32>DE_2^1_..-PE3 XB>'JK
M6+_IBJQ1@RDJP.01U%?87[./Q[MM<TV#P[KMRL.HP*$MYI#@2J. ,^H&/RKX
M\I\4SP2K)&Y213E64X(-<6;Y30SC#^QJZ-;/JG_6YV95FE;*J_MJ>J>Z[H_4
M<$$9!R*6OB/X>_M5>)/"<,5GJ:+K5FF%!E;$@'^]@DU[3I'[7O@R\C47B7MI
M,>H$(91^.:_#\;PKFF$DTJ?.N\=?PW1^PX3B7+L5%-U.1]I:?CL>YTA.*\/U
M7]KOP39QL+47UW,!P/) 4_CFO&_B#^UAXA\3Q2VFD1+HUHW&]'S(1ZYP,4L'
MPMFF+DDZ?(N\M/PW'B^),NPL6U4YGVCK_P  ]E^/7[0-EX(T^;2M&G2ZUN4%
M"8SD0#U)]:X3X)_M22)+#HWBV3>C';'J!&-OLP'^%?,<\\EU,\TSM)*YW,['
M))]:CK]7H<)9?3P3PE1<TGJY=;^79>7WGYI6XGQT\6L3!VBOL]+>?^9^HMI>
M07]ND]O*DT+C*NAR"*FKX2^#7[0>J_#BXAL;UVOM#) :%CEHAZK_ (5]I^$_
M%^E^-='BU+2;E;FV<<E3RI]#[U^09SD.)R>I[ZYH/:2V^?9GZEE.=8?-8>X[
M36\?\NZ->7_5/]#7YM?$;_D>=;_Z^6K])9?]4_T-?FU\1O\ D>=;_P"OEJ^N
MX"_CU_1?F?+\:_P*/J_R.<HHHK]G/R4^I/V:?@';W=I9^+M<19XI1YEG;'D$
M=G/X_P J^IE4(H50%4#  Z"N!^ G_)'?"G_7F/\ T(UW]?S)GN.KXW'U76E?
ME;271).Q_0^2X.C@\%35)6YDF_-M'(_%'X?6GQ(\)7>DW 596&Z"8CF-\<&O
MST\1:#=^&-9NM-OHFAN+=RC*P_6OTYKYY_:H^$/_  D.D_\ "3:7!F_M%_TA
M$',D?K^&2?PKZ;A#._J5?ZE7?[N;T\G_ ),^?XIR?ZY1^MT5[\-_-?\  /CJ
MBBBOW4_&#Z'_ &6OC'_PCVI#PSJL^W3[EO\ 1Y'/$;^GT.!^=?88((!!R#7Y
M<0RO!*DL;%)$8,K \@CH:^Y/V<?B\OQ!\-C3[Z4?VS8J%<$\R(. W\L^]?CG
M&61\DO[2PZT?Q+S[_P"9^K\*9QSKZA7>J^%_I_D>R4445^3GZ8%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-4U_3=$0OJ&H6
MUD I?]_*J' ZD GFOE+]I;]KM-'N-+T;X?ZVC7_VA6N[N&,.H0\;/G'7D'CT
MKTK]H/\ 9@@^/6I:?=RZ_)HYM$V!4MA+NZ^K#UKXZ_:"_9L@^ =[H+0Z[)K'
MVV49WVXBV8/LQSTJXI"9^C?@;4;C5_!VC7MW)YMS<6L<DCX W,1R>*Y#X[?&
M_2_@AX3.IWB?:[V4[+6S4_-(W^ ZFNE^&G_)/_#W_7E%_P"@BOF']J3X:>,/
MB9\;?"T=OH%]?>%[;R1//#$7B \T[R3_ +II)78'(6WQD_:-^*8_M7PEI,]I
MII)VK;Q0[2,\<R\UJ^%/VN/B#\,?$MOHGQ3T5Q"[!);MT"R1\\D;/E(]<9K[
M3TK2[;1=.MK&SB6"VMXUCCC08 4# KY\_;LT[2KCX+2W5ZD?VV&ZC%M(0-X)
MSD ^AP,T[IZ6 ^@M'U:UU[2[74+*59[2Y021R+T(->">+?VF=6\._M)6/PUB
MT>RET^X>!3>N[^:-\6\\9QP>*ROA'KGC/3/V0].O?#5J]]K\40%C%Y7G%U\T
M@_*>O&ZOD?Q-XJ^)MW\>K36-4TIXOB$C0F*R-H%8D1X3]WWRO-"07/O[]I^]
MN-/^"GB&>UGEMIUA)66%RC#@]".:Y+]B/5+S5O@^)KZ[GO9OM!'F7$K2-T]2
M:X/7?%'Q*\3?LZ^-9/B-I;Z9=HF+=7M!!N7#9X[UYO\ !7]I&;X:_"JS\->&
MM,;6_%-W.62!!D1CZ8.3QTHMH!^@]%?"FI_M#_M%>$D&KZ]X7:WT6-]T@FTT
M1J5]-_;ZU]'_ +._[0&G_'3P[-.D(LM7L\"[M VX)GH0?0D'MVI--!<]<HHH
MJ1GYU?$W2O%GQ&_:F\0^%-%\2W6E-+=2>7ONY4A0*,XPIX_ 5V7_  Q-\6O^
MBDP?^!UW_A570F"_M[:H6( ^T3\G_=K[I^T1?\]$_P"^A5MV$?$'_#$WQ:_Z
M*3!_X'7?^%>N^(O".O\ PM_9?U72]3UEK_5[:!B;Z":0D\=F;#5]!">,_P#+
M1/\ OH5YG^TO_P D6\2_]>[?R-*]P/-_V#M7O]8^&.I2W][<7THO,![F5I&
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MOQK9M8^(')\Z%H?)(&!CY>W>N[I#"BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME[D\+4<>;>W6QP8O 8;'<JQ,%*VU_,^??^&-_#/_ #_W7^?QH_X8W\,_\_\
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M?7K/;7<:[&EBZN.P/TKTRBNO"XNO@JBK8>3C)=4<V(PU'%TW2KQ4H]F?/O\
MPQOX9_Y_[K_/XT?\,;^&?^?^Z_S^-?05%>U_K)FW_01+\#R?[ RS_GPCY]_X
M8W\,_P#/_=?Y_&O;O#&ACPUH%EI@N)+I;9-@EE.689[UJ45Y^,S7&X^*ABJC
MDEJKG;A<MPF"DY8>FHM[V"BBBO*/2"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^=?VL/@3XG^,L_AY_#WV/%B^Z;[7.8^,D\<'-?1
M5%-.P&-X-TF?0O"FDZ?<[?M%M;)%)L.1N P<&ODGX\_LO_$WQ_\ %R]\4>'Y
M]/MK<,OV29KTQRJ!SGA>#G/>OL^BA.PCX7_X9^_:7_Z'9_\ P>2__$T?\,_?
MM+_]#L__ (/)?_B:^Z**?,%CS_X'>&_%7A7P#9V'C&_.I:VA/FSFX,^>>/F/
M)KQ/]IO]E?Q'\1O'=OXO\'7L%OJS*B3+/,8=NQ0JLK 'G _6OJRBE>PSY>T'
MX(?%&[^"_BCPYXIUE-7UN_\ EM3<7S3(@P?XB..OI7H7[,/PNUKX2_#H:+KW
MV?[;YQ?_ $:3S%QCUP*]?HHN(BNHS-:S1K]YD*C/J17S1^S=^SUXL^%GQ*\1
M:YK?V'[#?KB'[-.7?JW48&.HKZ<HHN,****0'S!I?[._BRS_ &IK[Q_(+'^P
M)II77%P?.PPP/EV_UKZ?HHIWN 5Q/QE\(W_CKX<:SHFF>5]MNX2D?G/M7..Y
MP:[:BD!XE^RE\(M?^#G@>]TKQ!]E^U37/FK]EE\Q=N,=<"E_: _9AT/XVQ"^
M\PZ;KT2;8[Q%R''8,.,_TKVRBG?J!\*?\,P_'_03+8:'XQVZ4AVQ :M)%N7'
M= "!7=_";]B8:7XDB\2>.]5;7-2C99!;YW(7QU9B?FQ[BOK"BGS,5AH10FP*
M N,8[5\J_%[]B>'7-?F\1>"=2.AZG(6D:#[J;\<%6!^7/TKZLHI)V&?"J?LR
M_M ZQY=AJ_C(_P!EO\DH_M:27"X[*0 :]Y_9\_9<T7X)(;]Y?[3U^5-KW;K@
M1CNJC)Q]>]>XT4-MBL>._M1?"O6_B[\._P"Q=!^S?;?.5_\ 2I?+7 ([X/I7
M4?!+P;J'@'X:Z1H>J>5]NM4*R>2^Y,Y[' KNJ*+]!A1112 **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@WA_]J%=3^/-]
M\.+_ $1-.-O(\:W[7.=Y5-P^7:.O3K7N[J'4JP!4C!![BODG]K+]G[7;WQ';
M_$/P4KG5;7:]Q!!]]BIR' [GV]JYOPO^WQJOA73X;+QIX2NYM01=OF1?N"^#
MC)#]_7WJK7V$?1WQ!_9Q\"?$6RECOM#MK>Z9-JWEM&$E7T^8#/%?+?[(D%U\
M/OVB?$'A"WNVNM/ >-V!PK;5+ X]>@_"M;Q1^W1XB\;:?+8^!/"-[;WDP$8G
M=3<-'GNNP<'TS7H/[(OP U7P&]_XN\4_\AW4U^6)CEHE/))]SDT]EJ!YS\:/
MB1XV^-'QH?X=>$=0ETK3H&\N5XI"F_ ^8N1V!R,?2MS0_P#@GCI_FM<:[XIG
MOY9!EDC@V$-W^;<<UQ/Q<TOQ)^SI^T+)XVL-,EU#1[I_.+QQED((RRL1]TY]
M?2NV?_@H$VO6WV7P[X&U&XU5L!07$RY_W4&:>O01Y'\?_A)X?^#GQL\":/X>
M29;>46LTIFDWLS_:",Y^@%?>'Q._Y)=KG_7B?Y"OSZ^-OASX@:-X@T#XA>-(
MGFDNIX[A;=%.+95?<(R>W3OZU]EZ-\5(/C%^SOJGB*WL9-/22UEA,,KACE#M
M)R.Q(H?09Y9_P3R4#PQXB..3.O/XFOKZOD+_ ()Y?\BOXB_Z[K_,U]>U,MP1
M\'_"+_D]77/^NL__ *,%?>%?!_PB_P"3U=<_ZZS_ /HP5]X42!!7PK\>?^3V
MO#7^_:?^@"ONJOA7X\_\GM>&O]^T_P#0!3CN#/NB/_5K]!3J;'_JU^@IU0,\
M4_;#_P"2"Z_]!_)JSOV)O^2%:=_UV;^2UH_MA_\ )!=?^@_DU9W[$W_)"M._
MZ[-_):KH+J==^T1\4I/A)\,]0UFV0/?L/*M@W3>>Y_#-?*/@#]G#QM^TKHB^
M*/%?BZ>UM;MR\"RJ9CCMA2PVCGBOI_\ :C^&MW\3OA/J-AIZB34+?_2((_[[
M#J!^&:^7_@[^V#=_!+PK%X4\3^%KVXDLV*Q%3Y#@>A#CM36V@'HFJ?L->"O!
MO@O7]4O+N[U*\L],N)HF+^6OF+&Q!(Y[@<52_P""<G_(L>+?^OR/_P! %9WB
M+XL?$?\ :BL;W0_"F@W'AO03&SSW=RIW2(%SLW<!LXQ@>M<I^QK\4&^%GCR\
M\ ZCI-Q)=ZO?>6)L[/)9%/)4\D';^M/6PC<N #^WE!D9Q,I_\>K[FKX:G_Y/
MRA_ZZK_Z%7W+4OH-'Q9_P4#_ .0[X)_WO_9ZT_VT(I6^ 'AEU!\E7B#D=,D#
M%9G_  4#_P"0[X)_WO\ V>OH#QI\,X/BU\$(_#TQ5))K1'@D8<)*%^5OP)I]
M@+G[.MU;WGP4\)2VI!A-IQC_ 'VS7HLDBPQO([!40%F8] !U-?GY\-?CAXS_
M &4[B\\+>*_#]UJ&C02$Q8!7;Z;)#\I4]>_)-;?Q _;9USXF:)-HG@CPM?6E
MQ=CR9)L&>10?[NP<'ZT<K"Y]A^%?B?X3\<W4]MX?\0Z?K%Q  98[2<.R#WQ]
M#7QI^SO_ ,G=^(?^NDO_ *":]L_8]^!5Y\)?"=UJ&LH(]:U7:TL74QH,E0??
MYC7B?[.__)W?B'_KI+_Z":%U ^H/CG\ -!^..E0PZB[6FH6P/V:\C&63/4$=
MQ[9[5\VW'[+WQH^&I7_A"O%TMS8PXQ$ETT&Y5Y4;!G/?BN@_;$\ >,=*\;:9
M\0?"_P!JN(K=5$\-LS,490 IV#J" >U5=(_X*(0:=9+;:_X.O&U2,XE\B58E
M'_ 6R10K] ,K1/VFOBI\(/&%AHOQ)THRV-RZJLCQ%&8$XWJY^\ ?Y5U'[?-S
M_:7PZ\-ZA 6:QEN4<-V^8$C/X5Y=XH\1>+_VPOB%H,=EX<ETW2+*16$TL9"A
M Q)+.>"<9Z5]>_%[X-V_Q'^$;^$@RB>WA3[)*W19$7:I_4T;-"-/X$W5O>?!
M_P )S6I!MVL4V;>F*[BXN([6"2>9UCAC4N[L<!5 R2:^ ?AC^T'XP_9@2X\)
M>,/#EU?:7:.1#M&QDSQA9#\I7@8Q[UI_$7]LSQ#\6M%D\/\ @CPO?6CWH\B:
M7!GD /8%!@>^>V:7*QW/9/VDOB)X:^('P(\5)X:UVQUI[6,-.ME,)#&,-UQT
MI_["UU;7'P/A6 C?%>2)*!_>VIG^E0_LY?LV_P#"'?"'6-(\11H;[Q"@^UQC
MG8N#M7Z_-S7@6C7OQ"_8V\9ZA;G3)M6\-7#%_P!VA:)EY^<$<*?KZ4]]$!^A
M=?#/[6TT=[^TIX/L[0@WZ>5O"]1NQM_D:V;[_@HA;ZA9&VT?P=>_VI(NV/?,
MLBEL?W5&35#]G+X1>+/BC\41\3_'$#V\<4GG6\4Z%&=P<KA3R%'OZT)6U8'V
MK9 BS@!ZB-<_E4]<#\<O'M]\,_AIJGB#38H)KNUV;$N 2ARP'(!!KEOV7/C-
MK'QK\&WNK:U;6EM<07 B5;-652,=\DU-NHSV>BBBD!\#^!+]/@?^V-JUEJ#_
M &6VU65T:1ONXE(E&3]<5]\5\\?M5?LWR?%FQ@US0-D'B:Q&5.=OG*.V?7I^
M5>*>!?VO/&_P>M?[#\>>&[S4(;,B-+AT:*4]L%V^4CC@@5>^PMC[RKYE_:D_
M:)\1?#'Q?X>\/>$Y;5[Z\YN(YH!*0"P '7C@YKA]<_X* W>OV3VOA+P;>#46
M! :8^?MSP"%3G-2?L]_L\>)O&7C9/B/\1=YE+^=;VEQ]\GMN'50!Q@X/2DE;
M<#T[]K#XB77@;X$SQ7$JC6=4C%H1'\H.X8<CZ9%?+GP@_9\^-5UX9@U_P;JR
MZ)8ZFOF#9J+6[R $C+ #U%=+^UWK]Q\6/COHO@73Y#)#:RI;#8<A97;:^?I@
M5]T^%=$B\-^&]-TN%!'':P)&%'3('/ZYIWL@/B>^_9[_ &E=2M);6Z\7-<6T
MJ[9(I-:<JP]",5SG[*6K:C\%/V@+WPAKQ6W>[)LYU5\J902$P>^2U?HA7P3^
MW%X3N/ OQ1T+QUIR&+[25Y4<"6([MQ^NX?E0G?0#[VHKE_ACXM@\<^ M%UJW
M<.MU;J6(.?F'#?J#745 SP;X^^"OAY\:[J/PK?\ B&QL/&$&3;(LBF=2>Q3(
M)'%>()^S#\>O"[MIOAWQBT>C*<)LU-X<KW^0 X_.MW]K;X2^)= \?V'Q.\(P
MRW,T&PSQ0J69&1MV[ Y(.><>E1Z7_P %#8[#3TM-9\'WKZNBA7,4JQJ7Q_=8
M9JU>V@CSOXU_LZ1?"CX;3^(/%.M2:SXOO[A((E+9"@ALMDGYN0.:]6\1:IK/
MPC_8ETM[%S9ZE/#%%*>ZB1MK8]\&N+T/1O&_[8/Q(T_5O$&G/I/@_3GR8G0H
MI&1\JAN6)QR1QQ[U]S)I=JMC%9M;Q26\:A5C= R\=.#0WW _-CX"?M16GP-T
MF\BA\(C5=3O7+W%_)>%&?GIC8<#IWZUI_'3]L>3XT> Y/#;>%UTH/.D_V@79
MDQM!&,;!Z^M?H?\ \(_I?_0-L_\ OPO^%?/W[<FDV-G\";B2"SMX)/M\(WQQ
M*IZ/W H338'C?[-W[74GAK3O"_@(>&EG5IH[3[=]J(/S.!NV[>V?6OO6O#_V
M1M*LI/@7X9G>S@:;RL^8T2ELYZYQFO<*3!'PA9_\GWG_ *^C_P"AU]8?'G27
MUKX2>)K>--["SDEQC/W5+?TKY/L_^3[S_P!?1_\ 0Z^ZKJVCO;6:WF4/%*AC
M=3W4C!%#Z CY:_X)]:[%>_#;5M-W 3V5W@IWPV3G]:^JJ^!=?TGQI^R%\5;[
M6-&L9=4\+ZE(TK)'&70J3N*G'W2.@SV%=+KO_!0677=)FLO#/A&]CUF1"(W=
MQ,%/J%49IM7U0&9KER/&O[<UM:VF)!92%"PY'RQES5__ (*$>.-4L;_P]X<B
MF9-)N8FN;B%#@R%6  )],$UV'['_ ,%-:T:_U'Q_XMC9=8U0$PQS#YT!ZL1U
M!/(P>U?4%UIMG?,&N;6"X9> 98PQ'YBB]F!\%> /VZ+3X=>$[#0-*\!(EI:1
MA ?[0.7..6/[OJ<5YC\<?VBG^,OC3P_K[:&-+.E! (!<>9YFV0OUVC'7%?IY
M_P (_I?_ $#;/_OPO^%?$W[;MA:VGQF\ QP6T,*,D&Y8T"@_Z0>H%--7 ]=_
M9N_:ID^-GB&706\.KI(M+/S?/%SYF[:57&-H]:^C*S-"TRSL]/M7M[2"!S"H
M+1QA2>!W K3J& 4444AA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8
MU_X,\/ZI*)+W0M-O)!G#SVD;GWY(K9HH R]-\*Z+HS[M/T>PL6SG-M:I&<_@
M!6I110!7OM.M-4@,%Y:PW<)ZQSQAU/X&L_3_  ;H&DSB:QT/3;*8<B2WM(XV
M'X@5L44 4]3T>PUJW\C4+*WOX,Y\JYB61<_1@13;30M-T^P-C:Z?:VUD<YMH
M852,YZ_*!BKU% %#2M!TS0D=--TZTT]'.66U@6(-]=H%7Z** ,R#PQH]KJ+7
M\.DV,-\V2UU';(LISURP&:TZ** "LVY\,Z/>ZBFH7&E6,]^F-MU+;(TJXZ88
MC(K2HH .E%%% %:_TZTU6V:VO;6&\MW^]#<1AT/U!XI-.TNRTBV%O86D%E;C
MD16\2QH/P  JU10 5C7_ (,\/ZK.9[W0M-O)CUDN+.-V/XD5LT4 5[+3[738
M!#:6T-K".D<$811^ JB/"6AC4AJ T;3Q?@[A=?94\T'UWXSG\:UJ* ,T^&M(
M.I_VB=*LO[0'/VO[.GF_]]XS^M:5%% &=JGAW2M<:-M2TRSU!H_N&ZMTE*_3
M<#BK\<:0HJ1JJ(HP%48 'TIU% %#5- TO6U"ZCIMI?J. +J!9!_X\#4&F^$M
M#T:7S-/T;3[&3.=]M:QQG\P!6M10 5F6GAC1K"^>]MM)L;>]?[US%;(LC?5@
M,UIT4 ->-94*.H=3P589!K#G\ ^&+J9I9O#FDS2L<L\EC$S$^Y*UO44 5;#2
M[+2H?*LK."SB'\%O$J+^0%6J** ,[5/#NE:WC^T=,L[_ !_S]6Z2?^A U'IG
MA31-%D\S3]'L+!^NZVM4C/YJ!6K10 57O=.M=2A,5W;0W41!!2>,.ISUX-6*
M* ,&#P#X8M9EEA\.:3#*IRKQV,2L/H0M;B1K$BHBA$48"J, "G44 <E\5=9M
M="\":I=7>FG5T\O8EF(A)YCMPGRGCJ17!_LK?#S4? 7@*Z?5+<65UJMT]Y]D
MQCR59B57CCH17M-%.X!1112 *SM3\.:3K?\ R$=+LK__ *^K=)/_ $(&M&B@
M#&L?!?A[3)O-L]"TRTE_OP6<:-^8%;-%% &2/"6AKJ1U :-IXORV\W0M8_-W
M>N_&<^^:UJ** "J.JZ%INNQ+'J6GVNH1H<JEU LH!]@P-7J* *VGZ;::3:I;
M6-K#9VR?=AMXQ&B_0 8JS110 UT61"KJ&5A@JPR"*PYO 7AFXG,TOAW29)B<
MF1[&(L3ZYVUO44 0VMI!90B&WACMXATCB4*H_ 5-110 54U+2;'6;8VVH6=O
M?6Y(8PW,2R)GUPP(JW10!7L-/M=+M4MK*VAM+=.%A@C"(OT X%6*** ,P>&-
M'&I_VB-)L1J&<_:_LR>;G_?QG]:TZ** (+NRM]0A,-U;Q7,1ZQS('4_@:RK3
MP+X;L)Q-;>'M*MIATDBLHE8?B%K<HH 0    8 I:** "LW4O#>D:S<17%_I5
ME?3Q8\N6YMTD9.<\$@D<UI44 (JA0   !P .U+110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!^5?_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._Z
MHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444
M'_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1
M_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q44
M4 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU
M_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J)_\ EU__ '%1_P /SO\ JB?_
M )=?_P!Q444 '_#\[_JB?_EU_P#W%1_P_._ZHG_Y=?\ ]Q444 '_  _._P"J
M)_\ EU__ '%1_P /SO\ JB?_ )=?_P!Q444 '_#\[_JB?_EU_P#W%1110!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001217234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">CAREDX, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">CareDx, Inc. 2024 Equity Incentive PlanCommon Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">14.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 23,248,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 3,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement on Form&#160;S-8&#160;(the &#8220;Registration Statement&#8221;) shall also cover any additional shares of common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), of CareDx, Inc. (the &#8220;Registrant&#8221;) that become issuable under the CareDx, Inc. 2024 Equity Incentive Plan, as amended by Amendment No. 1, dated as of April 23, 2025 (the &#8220;2024 Plan&#8221;) and the CareDx, Inc. 2025 Inducement Equity Incentive Plan (the &#8220;2025 Inducement Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#8217;s outstanding shares of Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the number of additional shares of Common Stock that were reserved for issuance under the 2024 Plan.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price with respect to these shares are calculated based on $14.53 per share, the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on October 30, 2025, a date within five business days prior to the filing of this Registration Statement.</span><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">CareDx, Inc. 2025 Inducement Equity Incentive PlanCommon Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">14.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,085,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement on Form&#160;S-8&#160;(the &#8220;Registration Statement&#8221;) shall also cover any additional shares of common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), of CareDx, Inc. (the &#8220;Registrant&#8221;) that become issuable under the CareDx, Inc. 2024 Equity Incentive Plan, as amended by Amendment No. 1, dated as of April 23, 2025 (the &#8220;2024 Plan&#8221;) and the CareDx, Inc. 2025 Inducement Equity Incentive Plan (the &#8220;2025 Inducement Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#8217;s outstanding shares of Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the number of shares of Common Stock that were reserved for issuance under the 2025 Inducement Plan</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price with respect to these shares are calculated based on $14.53 per share, the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on October 30, 2025, a date within five business days prior to the filing of this Registration Statement.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 28,333,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">4,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 4,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2025": 2,
    "http://xbrl.sec.gov/ffd/2025": 4
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 28,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001217234-25-000064-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001217234-25-000064-xbrl.zip
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-  $ /@   &\-      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001217234</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-3" id="f-25">0001217234</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-3" id="f-26">CAREDX, INC.</dei:EntityRegistrantName>
    <ffd:FormTp contextRef="c-3" id="f-27">S-8</ffd:FormTp>
    <ffd:SubmissnTp contextRef="c-3" id="f-28">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c-3" id="f-29">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OffsetTableNa contextRef="c-3" id="f-30">N/A</ffd:OffsetTableNa>
    <ffd:PrevslyPdFlg contextRef="c-1" id="f-1">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c-1" id="f-2">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c-1" id="f-3">CareDx, Inc. 2024 Equity Incentive PlanCommon Stock, par value $0.001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c-1" id="f-4">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd contextRef="c-1" decimals="0" id="f-5" unitRef="shares">1600000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty contextRef="c-1" decimals="2" id="f-6" unitRef="usd">14.53</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric contextRef="c-1" decimals="0" id="f-7" unitRef="usd">23248000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c-1" decimals="8" id="f-8" unitRef="number">0.00015310</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">3560</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="c-2" id="f-10">Equity</ffd:OfferingSctyTp>
    <ffd:PrevslyPdFlg contextRef="c-2" id="f-11">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTitl contextRef="c-2" id="f-12">CareDx, Inc. 2025 Inducement Equity Incentive PlanCommon Stock, par value $0.001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c-2" id="f-13">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd contextRef="c-2" decimals="0" id="f-14" unitRef="shares">350000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty contextRef="c-2" decimals="2" id="f-15" unitRef="usd">14.53</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric contextRef="c-2" decimals="0" id="f-16" unitRef="usd">5085500</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c-2" decimals="8" id="f-17" unitRef="number">0.00015310</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c-2" decimals="0" id="f-18" unitRef="usd">779</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="c-3" decimals="0" id="f-19" unitRef="usd">28333500</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c-3" decimals="0" id="f-20" unitRef="usd">4339</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt contextRef="c-3" decimals="0" id="f-21" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c-3" decimals="0" id="f-22" unitRef="usd">4339</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c-1" id="f-24">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement on Form&#160;S-8&#160;(the &#x201c;Registration Statement&#x201d;) shall also cover any additional shares of common stock, $0.001 par value per share (the &#x201c;Common Stock&#x201d;), of CareDx, Inc. (the &#x201c;Registrant&#x201d;) that become issuable under the CareDx, Inc. 2024 Equity Incentive Plan, as amended by Amendment No. 1, dated as of April 23, 2025 (the &#x201c;2024 Plan&#x201d;) and the CareDx, Inc. 2025 Inducement Equity Incentive Plan (the &#x201c;2025 Inducement Plan&#x201d;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#x2019;s outstanding shares of Common Stock.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents the number of additional shares of Common Stock that were reserved for issuance under the 2024 Plan.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price with respect to these shares are calculated based on $14.53 per share, the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on October 30, 2025, a date within five business days prior to the filing of this Registration Statement.&lt;/span&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c-2" id="f-23">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement on Form&#160;S-8&#160;(the &#x201c;Registration Statement&#x201d;) shall also cover any additional shares of common stock, $0.001 par value per share (the &#x201c;Common Stock&#x201d;), of CareDx, Inc. (the &#x201c;Registrant&#x201d;) that become issuable under the CareDx, Inc. 2024 Equity Incentive Plan, as amended by Amendment No. 1, dated as of April 23, 2025 (the &#x201c;2024 Plan&#x201d;) and the CareDx, Inc. 2025 Inducement Equity Incentive Plan (the &#x201c;2025 Inducement Plan&#x201d;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#x2019;s outstanding shares of Common Stock.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents the number of shares of Common Stock that were reserved for issuance under the 2025 Inducement Plan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price with respect to these shares are calculated based on $14.53 per share, the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on October 30, 2025, a date within five business days prior to the filing of this Registration Statement.&lt;/span&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
